http://cardiobrief.org/2012/02/02/cms-releases-details-of-proposed-national-coverage-for-tavr/2012-02-04T01:14:25+00:00monthlyhttp://cardiobrief.org/2012/02/02/study-explores-role-of-periprocedural-dabigatran-in-af-ablation/2012-02-03T00:45:57+00:00monthlyhttp://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/2012-02-01T18:18:12+00:00monthlyhttp://cardiobrief.org/2012/01/30/very-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients/2012-02-01T18:17:08+00:00monthlyhttp://cardiobrief.org/2012/01/30/appropriate-use-criteria-for-revascularization-updated/2012-02-01T18:14:50+00:00monthlyhttp://cardiobrief.org/2012/01/30/robert-harrington-leaving-duke-for-stanford-university/2012-02-01T18:11:45+00:00monthlyhttp://cardiobrief.org/2012/01/31/consensus-document-provides-roadmap-to-uptake-of-tavi-in-us/2012-02-01T18:10:21+00:00monthlyhttp://cardiobrief.org/2012/02/01/meta-analysis-confirms-benefits-of-statins-in-women/2012-02-01T17:55:03+00:00monthlyhttp://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/2012-01-27T19:02:17+00:00monthlyhttp://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/2012-01-26T17:20:55+00:00monthlyhttp://cardiobrief.org/2012/01/26/big-drop-in-incidence-and-fatality-of-mis-in-england/2012-01-26T16:15:52+00:00monthlyhttp://cardiobrief.org/2012/01/25/huge-study-finds-risk-factors-do-in-fact-predict-risk/2012-01-27T15:58:13+00:00monthlyhttp://cardiobrief.org/2012/01/25/fda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin/2012-01-25T19:24:02+00:00monthlyhttp://cardiobrief.org/2012/01/24/whistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania/2012-01-24T16:41:28+00:00monthlyhttp://cardiobrief.org/2012/01/24/black-tea-found-to-lower-blood-pressure/2012-01-24T14:36:29+00:00monthlyhttp://cardiobrief.org/2012/01/21/guest-post-report-from-the-riata-icd-lead-summit/2012-01-24T14:17:20+00:00monthlyhttp://cardiobrief.org/2012/01/23/st-jude-medical-statement-on-the-riata-icd-lead-summit/2012-01-23T19:01:22+00:00monthlyhttp://cardiobrief.org/2012/01/23/rita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal/2012-01-26T00:53:17+00:00monthlyhttp://cardiobrief.org/2012/01/19/ct-angiography-found-less-helpful-in-patients-with-high-calcium-scores/2012-01-19T18:57:43+00:00monthlyhttp://cardiobrief.org/2012/01/18/guest-post-a-critical-analysis-of-abc-bill-weirs-lifesaving-test-story/2012-01-20T13:48:05+00:00monthlyhttp://cardiobrief.org/2012/01/18/new-enrollment-in-fame-ii-halted-after-interim-analysis-shows-benefits-of-ffr/2012-01-18T18:14:19+00:00monthlyhttp://cardiobrief.org/2012/01/18/fame-ii-additional-thoughts-about-ffr-in-the-real-world/2012-02-01T14:13:04+00:00monthlyhttp://cardiobrief.org/2012/01/17/cangrelor-proposed-as-bridge-to-surgery/2012-01-17T21:41:20+00:00monthlyhttp://cardiobrief.org/2012/01/16/resveratrol-and-fraud/2012-01-16T22:28:54+00:00monthlyhttp://cardiobrief.org/2012/01/12/the-safety-of-the-long-distance-runner/2012-01-12T19:59:58+00:00monthlyhttp://cardiobrief.org/2012/01/11/director-of-uconn-cv-research-center-accused-of-scientific-misconduct/2012-01-11T23:44:40+00:00monthlyhttp://cardiobrief.org/2012/01/11/assert-sheds-light-on-the-role-of-subclinical-af-in-stroke/2012-01-11T22:00:26+00:00monthlyhttp://cardiobrief.org/2012/01/10/researcher-find-lower-sweet-spot-for-potassium-levels-in-mi/2012-01-11T01:04:39+00:00monthlyhttp://cardiobrief.org/2012/01/09/excess-risk-of-cardiac-events-associated-with-dabigatran/2012-01-09T21:59:36+00:00monthlyhttp://cardiobrief.org/2012/01/09/statins-elevate-risk-of-diabetes-in-postmenopausal-women/2012-01-09T19:20:03+00:00monthlyhttp://cardiobrief.org/2012/01/05/researchers-report-a-new-placebo-effect-manipulating-clinical-trials/2012-01-06T18:19:51+00:00monthlyhttp://cardiobrief.org/2012/01/05/diets-differ-in-effect-on-weight-gain-and-fat-and-lean-mass/2012-01-05T19:32:57+00:00monthlyhttp://cardiobrief.org/2012/01/04/high-stemi-readmission-rate-in-us-linked-to-shorter-hospital-stays/2012-01-04T17:55:35+00:00monthlyhttp://cardiobrief.org/2012/01/03/bariatric-surgery-cuts-cardiovascular-deaths-and-events/2012-01-04T16:35:31+00:00monthlyhttp://cardiobrief.org/2012/01/04/missing-data-the-elephant-thats-not-in-the-room-guest-post/2012-01-04T06:28:17+00:00monthlyhttp://cardiobrief.org/2012/01/03/measuring-in-hospital-mortality-favors-hospitals-with-short-stays/2012-01-03T15:50:21+00:00monthlyhttp://cardiobrief.org/2011/12/31/2011-in-review-rivaroxaban-sapien-mark-midei-conflicts-of-interest-and-much-more/2012-01-02T01:21:43+00:00monthlyhttp://cardiobrief.org/2011/11/13/adopt-fails-to-support-extended-oral-anticoagulation-with-apixabanin-high-risk-post-discharge-patients/2011-12-31T19:25:22+00:00monthlyhttp://cardiobrief.org/2011/12/29/jj-submits-nda-for-acs-indication-for-rivaroxaban-xarelto/2011-12-30T04:23:07+00:00monthlyhttp://cardiobrief.org/2011/12/28/no-mortality-benefit-found-for-low-molecular-weight-heparin-in-acutely-ill-patients/2011-12-28T22:02:48+00:00monthlyhttp://cardiobrief.org/2011/12/27/nissen-and-topol-clash-over-genetics-and-personalized-medicine/2011-12-27T21:35:39+00:00monthlyhttp://cardiobrief.org/2011/12/27/clopidogrel-testing-comes-under-fire/2011-12-27T21:10:28+00:00monthlyhttp://cardiobrief.org/2011/12/27/study-finds-role-for-new-troponin-test-in-diagnosis-of-mi/2011-12-27T21:04:00+00:00monthlyhttp://cardiobrief.org/2009/05/20/renaissance-man-eric-topol-rock-star-model-wireless-expert-skit-subject/2011-12-27T20:04:18+00:00monthlyhttp://cardiobrief.org/2011/12/22/ray-of-light-for-the-physician-payment-sunshine-act/2011-12-23T19:41:48+00:00monthlyhttp://cardiobrief.org/2011/12/23/study-finds-mr-superior-to-spect-but-clinical-role-is-uncertain/2011-12-23T15:45:06+00:00monthlyhttp://cardiobrief.org/2011/12/21/study-examines-changes-in-resting-heart-rate-over-time/2011-12-21T20:21:35+00:00monthlyhttp://cardiobrief.org/2011/12/20/22-years-later-study-shows-life-prolonging-effect-of-antihypertensive-therapy/2011-12-21T17:20:21+00:00monthlyhttp://cardiobrief.org/2011/12/20/altitude-study-of-aliskiren-terminated-early-by-novartis/2011-12-20T17:23:13+00:00monthlyhttp://cardiobrief.org/2011/12/19/more-uncertainty-about-vitamin-d-supplements/2011-12-19T22:29:17+00:00monthlyhttp://cardiobrief.org/2011/12/18/letter-from-jail-a-cautionary-tale/2011-12-19T21:13:38+00:00monthlyhttp://cardiobrief.org/2011/12/19/fda-adds-new-warnings-to-dronedarone-multaq-label/2011-12-19T20:52:25+00:00monthlyhttp://cardiobrief.org/2011/12/15/the-good-the-bad-and-the-ugly-aha-releases-update-of-heart-and-stroke-statistics/2011-12-15T21:17:56+00:00monthlyhttp://cardiobrief.org/2011/12/14/investigation-in-poldermans-case-expands-to-leiden-university-medical-center/2011-12-15T01:19:05+00:00monthlyhttp://cardiobrief.org/2011/12/14/study-examines-new-onset-atrial-fibrillation-after-tavi/2011-12-14T21:07:28+00:00monthlyhttp://cardiobrief.org/2011/12/13/meta-analysis-finds-no-danger-for-pci-performed-at-centers-without-surgical-backup/2011-12-14T13:59:02+00:00monthlyhttp://cardiobrief.org/2011/12/12/large-analysis-confirms-safety-of-adhd-medications/2011-12-12T16:44:55+00:00monthlyhttp://cardiobrief.org/2011/12/10/from-the-archives-understanding-risk-tricky-business/2011-12-12T21:07:09+00:00monthlyhttp://cardiobrief.org/2011/12/08/fda-advisory-panel-votes-against-implantable-cardiomems-hf-pressure-measurement-system/2011-12-09T00:21:34+00:00monthlyhttp://cardiobrief.org/2011/12/08/oops-she-did-it-again-fda-disinvites-another-advisor/2011-12-08T21:19:09+00:00monthlyhttp://cardiobrief.org/2011/12/07/cv-risk-of-prostate-cancer-therapy-underappreciated/2011-12-07T23:50:14+00:00monthlyhttp://cardiobrief.org/2011/12/07/fda-undertakes-safety-review-of-dabigatran-pradaxa/2011-12-07T19:23:16+00:00monthlyhttp://cardiobrief.org/2011/12/06/change-in-fitness-more-important-than-bmi-over-time/2011-12-06T17:46:15+00:00monthlyhttp://cardiobrief.org/2011/12/05/fda-reviewers-raise-questions-about-cardiomems-champion-trial-ahead-of-advisory-panel/2011-12-05T19:53:13+00:00monthlyhttp://cardiobrief.org/2011/12/04/cms-tightening-the-screws-on-unnecessary-procedures-in-florida-and-10-other-states/2011-12-07T04:00:14+00:00monthlyhttp://cardiobrief.org/2011/12/02/one-more-thought-about-lipitor/2011-12-04T00:17:50+00:00monthlyhttp://cardiobrief.org/2011/12/01/acc-and-sts-announce-launch-of-tavr-registry/2011-12-01T17:32:49+00:00monthlyhttp://cardiobrief.org/2011/12/01/meta-analysis-finds-benefits-for-self-monitoring-in-some-warfarin-patients/2011-12-01T14:07:18+00:00monthlyhttp://cardiobrief.org/2011/11/30/generic-atorvastatin-hits-the-market/2011-11-30T15:23:33+00:00monthlyhttp://cardiobrief.org/2011/11/29/apixaban-gains-priority-fda-review-for-stroke-and-vte-prevention-in-af/2011-11-29T16:43:16+00:00monthlyhttp://cardiobrief.org/2011/11/28/study-finds-10-of-pci-patients-readmitted-to-hospital-within-30-days/2011-11-29T15:06:54+00:00monthlyhttp://cardiobrief.org/2011/11/28/long-transfer-delays-for-stemi-patients-at-most-hospitals-without-primary-pci/2011-11-28T22:52:13+00:00monthlyhttp://cardiobrief.org/2011/11/17/prominent-dutch-cardiovascular-researcher-fired-for-scientific-misconduct/2011-11-30T04:33:26+00:00monthlyhttp://cardiobrief.org/2011/11/23/fda-investigating-conduct-of-cardiomems-champion-trial-ahead-of-advisory-committee-meeting/2011-11-23T22:56:21+00:00monthlyhttp://cardiobrief.org/2011/11/23/esc-may-re-examine-guidelines-in-wake-of-poldermans-dismissal/2011-11-23T18:54:19+00:00monthlyhttp://cardiobrief.org/2011/11/22/merck-pleads-guilty-and-pays-950-million-for-illegal-promotion-of-vioxx/2011-11-22T21:29:42+00:00monthlyhttp://cardiobrief.org/2011/11/22/long-term-followup-of-hps-shows-extended-benefits-of-statins/2011-11-22T16:59:38+00:00monthlyhttp://cardiobrief.org/2011/11/20/more-details-emerge-about-the-dutch-research-scandal/2011-11-21T17:21:56+00:00monthlyhttp://cardiobrief.org/2011/11/16/elevate-timi-56-one-new-piece-of-the-clopidogrel-puzzle/2011-11-16T18:02:12+00:00monthlyhttp://cardiobrief.org/2011/11/15/experts-clash-over-interpretation-and-value-of-aim-high/2011-11-15T20:33:57+00:00monthlyhttp://cardiobrief.org/2011/11/15/hype-aside-hope-for-stem-cell-therapy-may-be-emerging-from-hibernation/2011-11-17T21:47:27+00:00monthlyhttp://cardiobrief.org/2011/11/15/aim-high-no-benefit-for-niacin-on-top-of-statins/2011-11-15T13:22:09+00:00monthlyhttp://cardiobrief.org/2011/11/15/saturn-regression-trial-gorilla-statin-and-statin-king-battle-to-a-draw/2011-11-22T13:30:00+00:00monthlyhttp://cardiobrief.org/2011/11/14/pallas-poor-results-for-dronedarone-in-permanent-af/2011-11-14T18:29:30+00:00monthlyhttp://cardiobrief.org/2011/11/14/mi-freee-how-much-do-free-medications-really-cost/2011-11-14T14:01:10+00:00monthlyhttp://cardiobrief.org/2011/11/13/tracer-novel-anticoagulant-vorapaxar-runs-into-trouble-in-acs/2011-11-13T13:26:58+00:00monthlyhttp://cardiobrief.org/2011/11/13/atlas-acs-2-timi-51-rivaroxaban-beneficial-in-low-risk-acs-population/2011-11-13T13:09:43+00:00monthlyhttp://cardiobrief.org/2011/11/12/the-aha-starts-on-sunday/2011-11-12T16:52:08+00:00monthlyhttp://cardiobrief.org/2011/11/12/controversy-over-cholesterol-testing-for-children/2011-11-12T22:02:50+00:00monthlyhttp://cardiobrief.org/2011/11/10/tavi-at-tct-enthusiasm-tempered-by-poor-transapical-outcomes/2011-11-11T12:37:18+00:00monthlyhttp://cardiobrief.org/2011/11/10/cardiobrief-poll-should-the-acc-train-industry-reps/2011-11-11T12:29:51+00:00monthlyhttp://cardiobrief.org/2011/11/09/obstructive-lesions-found-in-patients-with-calcium-score-of-zero/2011-11-09T21:06:33+00:00monthlyhttp://cardiobrief.org/2011/11/09/18-months-after-accord-fda-says-fenofibrate-may-not-lower-mi-or-stroke/2011-11-09T17:38:22+00:00monthlyhttp://cardiobrief.org/2011/11/08/financial-incentives-increase-utilization-of-stress-tests/2011-11-08T22:24:47+00:00monthlyhttp://cardiobrief.org/2011/11/07/acc-and-aha-release-new-pci-and-cabg-guidelines/2011-11-07T21:42:11+00:00monthlyhttp://cardiobrief.org/2011/11/04/fda-approves-rivaroxaban-for-stroke-prevention-in-af/2011-11-30T00:33:30+00:00monthlyhttp://cardiobrief.org/2011/11/04/vytorin-yesterday%e2%80%99s-news-guest-post/2011-11-05T20:31:38+00:00monthlyhttp://cardiobrief.org/2011/11/04/aha-and-acc-update-secondary-prevention-guidelines/2011-11-04T03:20:04+00:00monthlyhttp://cardiobrief.org/2011/11/03/tavi-approval-an-alternate-perspective-guest-post/2011-11-04T17:32:09+00:00monthlyhttp://cardiobrief.org/2011/11/02/sapien-transcatheter-aortic-heart-valve-gains-fda-approval/2011-11-03T00:23:17+00:00monthlyhttp://cardiobrief.org/2011/11/02/fda-advisory-committee-recommends-approval-for-vytorin-in-pre-dialysis-ckd-patients/2011-11-02T20:53:57+00:00monthlyhttp://cardiobrief.org/2011/09/23/former-nejm-editor-criticizes-publication-and-peer-review-of-aristotle-trial/2011-11-02T12:50:40+00:00monthlyhttp://cardiobrief.org/2011/11/01/fda-approves-abbotts-xience-prime-drug-eluting-stent/2011-11-01T22:42:33+00:00monthlyhttp://cardiobrief.org/2011/11/01/daily-show-asks-why-the-aha-killed-a-bill-encouraging-healthy-behavior/2011-11-02T18:15:46+00:00monthlyhttp://cardiobrief.org/2011/11/01/large-study-finds-no-increased-risk-of-cv-events-for-adhd-drugs/2011-11-01T16:34:25+00:00monthlyhttp://cardiobrief.org/2011/10/31/waiting-for-tavi-on-all-hallows-eve/2011-11-01T18:49:28+00:00monthlyhttp://cardiobrief.org/2011/10/30/fda-gives-favorable-review-to-sharp-ahead-of-vytorin-advisory-panel/2011-10-30T20:59:39+00:00monthlyhttp://cardiobrief.org/2011/10/27/fda-advisory-panel-votes-8-2-against-approval-of-medtronic-af-ablation-system/2011-10-27T22:29:22+00:00monthlyhttp://cardiobrief.org/2011/10/26/belgian-study-supports-use-of-ffr-to-guide-therapy-in-intermediate-lad-lesions/2011-10-26T20:38:09+00:00monthlyhttp://cardiobrief.org/2011/10/25/danish-study-clarifies-vte-risk-associated-with-newer-progestogens-in-oral-contraceptives/2011-10-25T22:33:49+00:00monthlyhttp://cardiobrief.org/2011/10/25/genetic-and-clinical-factors-linked-to-stent-thrombosis/2011-10-25T20:13:21+00:00monthlyhttp://cardiobrief.org/2011/10/24/new-study-proposes-possible-causative-role-for-hpv-in-atherosclerosis/2011-10-24T22:33:48+00:00monthlyhttp://cardiobrief.org/2011/10/24/midlife-obesity-increases-risk-for-chd-mortality/2011-10-24T20:02:20+00:00monthlyhttp://cardiobrief.org/2011/10/20/cdc-and-aha-tussle-over-just-how-bad-the-salt-problem-really-is/2011-10-20T18:41:24+00:00monthlyhttp://cardiobrief.org/2011/10/20/emas-chmp-finds-no-cancer-link-for-arbs/2011-10-20T17:23:46+00:00monthlyhttp://cardiobrief.org/2011/10/19/uk-registry-tracks-long-term-tavi-outcomes/2011-10-19T21:23:51+00:00monthlyhttp://cardiobrief.org/2011/10/19/first-trimester-hypertension-not-ace-inhibitors-linked-to-birth-defects/2011-10-19T13:48:11+00:00monthlyhttp://cardiobrief.org/2011/10/18/heart-failure-hospitalization-rate-drops-30-in-10-years/2011-10-19T14:22:19+00:00monthlyhttp://cardiobrief.org/2011/10/12/national-lipid-association-expert-panel-has-many-deep-ties-to-industry/2011-10-17T20:06:41+00:00monthlyhttp://cardiobrief.org/2011/10/17/sapien-transcatheter-heart-valve-may-be-delayed/2011-10-18T13:37:54+00:00monthlyhttp://cardiobrief.org/2011/10/13/fda-panel-recommends-first-des-for-pad/2011-10-13T23:03:58+00:00monthlyhttp://cardiobrief.org/2011/10/13/coronary-heart-disease-prevalence-in-us-continues-to-decline/2011-10-13T17:57:54+00:00monthlyhttp://cardiobrief.org/2011/10/11/cardiologist-who-accused-famed-surgeon-of-misconduct-is-fired-by-northwestern-university/2011-10-13T16:49:03+00:00monthlyhttp://cardiobrief.org/2011/10/10/ttop-af-trial-demonstrates-efficacy-of-rf-ablation-system-but-fails-to-prove-safety/2011-10-10T20:45:07+00:00monthlyhttp://cardiobrief.org/2011/10/07/fda-approves-juvisync-combination-of-sitagliptin-and-simvastatin/2011-10-07T16:31:25+00:00monthlyhttp://cardiobrief.org/2011/10/07/industry-medicine-its-not-so-simple/2011-10-08T17:50:48+00:00monthlyhttp://cardiobrief.org/2011/10/06/disease-mongering-du-jour-heart-disease-in-young-women-red-competing-with-pink/2011-10-26T23:43:10+00:00monthlyhttp://cardiobrief.org/2011/10/05/jj-pleads-guilty-and-pays-85-million-to-settle-natrecor-case/2011-10-06T02:23:49+00:00monthlyhttp://cardiobrief.org/2011/10/05/rivaroxaban-roundup-nejm-perspective-on-fda-panel-atlas-acs-will-be-an-aha-late-breaker/2011-10-05T22:09:43+00:00monthlyhttp://cardiobrief.org/2011/08/16/aha-2011-in-orlando-late-breaking-clinical-trials/2011-10-05T17:50:38+00:00monthlyhttp://cardiobrief.org/2011/10/04/same-day-discharge-after-pci-safe-but-rarely-used/2011-10-05T00:25:40+00:00monthlyhttp://cardiobrief.org/2011/10/03/guidelines-for-peripheral-artery-disease-updated/2011-10-04T04:52:45+00:00monthlyhttp://cardiobrief.org/2011/09/29/atlas-acs-timi-51of-rivaroxaban-in-acs-meets-primary-endpoint/2011-09-30T01:05:33+00:00monthlyhttp://cardiobrief.org/2011/09/29/meta-analysis-explores-real-world-cv-risk-of-nsaids/2011-11-16T20:20:08+00:00monthlyhttp://cardiobrief.org/2011/09/29/study-finds-noncardiac-sources-of-positive-troponin-t-tests/2011-09-29T15:43:24+00:00monthlyhttp://cardiobrief.org/2011/09/28/easy-come-easy-go-esc-to-review-dronedarones-role-in-af-guidelines-2/2011-09-28T20:25:37+00:00monthlyhttp://cardiobrief.org/2011/09/28/the-pen-is-mightier-than-the-scold/2011-09-29T02:21:40+00:00monthlyhttp://cardiobrief.org/2011/09/27/experience-counts-in-carotid-artery-stenting/2011-09-27T20:21:17+00:00monthlyhttp://cardiobrief.org/2011/09/26/statins-for-primary-prevention-the-debate-continues/2011-09-27T20:58:33+00:00monthlyhttp://cardiobrief.org/2011/09/23/rivaroxaban-xarelto-gets-positive-recommendation-for-af-and-dvt-in-europe/2011-09-27T21:01:10+00:00monthlyhttp://cardiobrief.org/2011/09/22/dronedarone-multaq-gets-another-drubbing-in-europe/2011-09-22T16:48:59+00:00monthlyhttp://cardiobrief.org/2011/09/21/diet-drugs-get-a-new-slim-chance-at-approval/2011-09-22T14:50:42+00:00monthlyhttp://cardiobrief.org/2011/09/21/more-data-but-no-answers-about-platelet-function-testing/2011-09-21T19:00:49+00:00monthlyhttp://cardiobrief.org/2011/09/20/significant-declines-observed-in-cardiovascular-procedures-performed-in-hospitals/2011-09-21T17:09:30+00:00monthlyhttp://cardiobrief.org/2011/09/19/fda-approves-watson-pharmaceuticals-generic-lovenox-enoxaparin/2011-09-20T17:05:30+00:00monthlyhttp://cardiobrief.org/2011/09/19/study-identifies-slow-spots-in-transfer-of-primary-pci-patients/2011-09-19T21:16:37+00:00monthlyhttp://cardiobrief.org/2011/09/15/xanthelasmata-identified-as-independent-cv-risk-factor/2011-09-15T22:31:02+00:00monthlyhttp://cardiobrief.org/2011/09/14/meta-analysis-finds-reduction-in-stent-thrombosis-with-everolimus-eluting-stents/2011-09-14T20:51:44+00:00monthlyhttp://cardiobrief.org/2011/09/14/study-sheds-light-on-consequences-of-bicuspid-aortic-valve/2011-09-14T12:41:31+00:00monthlyhttp://cardiobrief.org/2011/09/13/hhs-announces-initiative-to-prevent-one-million-heart-attacks-and-stroke/2011-09-27T21:03:49+00:00monthlyhttp://cardiobrief.org/2011/09/12/study-finds-risks-and-costs-associated-with-infection-after-device-implantation/2011-09-13T18:01:16+00:00monthlyhttp://cardiobrief.org/2011/09/12/global-monitor-early-signs-of-possible-problems-with-icd-leads-dabigatran/2011-09-12T19:57:36+00:00monthlyhttp://cardiobrief.org/2011/09/08/live-blog-fda-advisory-panel-on-rivaroxaban-xarelto/2011-09-11T17:39:58+00:00monthlyhttp://cardiobrief.org/2011/09/09/the-rivaroxaban-fda-panel-and-large-pragmatic-trials/2011-09-10T00:29:18+00:00monthlyhttp://cardiobrief.org/2011/09/07/stenting-worse-than-medical-therapy-for-intracranial-stenosis/2011-09-07T19:47:23+00:00monthlyhttp://cardiobrief.org/2011/09/06/fda-reviewers-recommend-against-approval-of-rivaroxaban-xarelto/2011-09-07T14:01:47+00:00monthlyhttp://cardiobrief.org/2011/09/06/fda-reviewers-recommend-complete-response-letter-for-rivaroxaban-xarelto/2011-09-06T14:43:20+00:00monthlyhttp://cardiobrief.org/2011/09/05/cnn-documentary-promises-screening-and-vegan-diet-can-eliminate-heart-attacks/2012-01-19T22:06:46+00:00monthlyhttp://cardiobrief.org/2011/09/04/montreal-heart-institute-researcher-fired-after-investigation-of-retracted-papers/2011-09-05T10:12:24+00:00monthlyhttp://cardiobrief.org/2011/09/02/rosuvastatin-fails-to-best-atorvastatin-in-ivus-study-of-atherosclerosis-progression/2011-09-02T21:23:27+00:00monthlyhttp://cardiobrief.org/2011/08/31/new-resuscitation-strategies-fail-to-improve-outcomes-after-cardiac-arrest/2011-08-31T21:07:03+00:00monthlyhttp://cardiobrief.org/2011/08/30/no-benefit-for-routine-counterpulsation-found-in-crisp-ami/2011-08-30T11:14:03+00:00monthlyhttp://cardiobrief.org/2011/08/30/paris-or-orlando-a-tale-of-two-cities/2011-08-30T09:34:41+00:00monthlyhttp://cardiobrief.org/2011/08/29/more-emphatic-benefits-found-for-high-risk-subgroups-taking-eplerenone/2011-08-29T17:10:22+00:00monthlyhttp://cardiobrief.org/2011/08/29/not-shocking-french-studies-evaluate-remote-monitoring-of-icds/2011-08-29T11:35:02+00:00monthlyhttp://cardiobrief.org/2011/08/29/shortfalls-in-secondary-prevention-represent-a-colossal-human-tragedy/2011-08-29T06:54:52+00:00monthlyhttp://cardiobrief.org/2011/08/28/aristotle-study-finds-the-golden-mean-of-anticoagulation/2011-08-28T20:30:13+00:00monthlyhttp://cardiobrief.org/2011/08/26/paris-is-beautiful/2011-08-26T20:43:59+00:00monthlyhttp://cardiobrief.org/2011/08/23/ambulatory-bp-monitoring-gains-nice-recommendation-in-uk/2011-08-23T22:32:12+00:00monthlyhttp://cardiobrief.org/2011/08/23/door-to-balloon-time-closing-in-on-one-hour/2011-08-24T23:16:47+00:00monthlyhttp://cardiobrief.org/2011/08/23/william-kannel-former-director-of-the-framingham-heart-study-dead-at-87/2011-08-23T04:47:10+00:00monthlyhttp://cardiobrief.org/2011/08/22/why-health-journalism-shouldnt-be-a-popularity-contest/2011-08-22T19:06:40+00:00monthlyhttp://cardiobrief.org/2011/08/22/cnn-abc-and-nbc-dumb-down-the-news-about-cv-screening/2011-08-22T20:52:10+00:00monthlyhttp://cardiobrief.org/2011/08/18/is-coronary-calcium-better-than-crp-for-predicting-cv-events/2011-08-19T16:25:49+00:00monthlyhttp://cardiobrief.org/2011/08/17/details-of-updated-uk-heart-failure-guidelines-raise-some-eyebrows/2011-08-17T12:38:49+00:00monthlyhttp://cardiobrief.org/2011/08/16/meta-analysis-finds-beta-blockers-may-be-less-effective-in-us-population/2011-08-16T16:32:02+00:00monthlyhttp://cardiobrief.org/2011/08/15/bare-metal-stents-the-next-new-thing/2011-08-15T02:55:07+00:00monthlyhttp://cardiobrief.org/2011/08/12/guest-post-when-patients-cant-afford-a-medication/2011-08-15T15:18:16+00:00monthlyhttp://cardiobrief.org/2011/08/11/danger-of-cigarettes-greater-in-women-than-in-men/2011-08-11T16:04:27+00:00monthlyhttp://cardiobrief.org/2011/08/10/rivaroxaban-xarelto-compared-to-warfarin-in-af-patients/2011-08-10T21:03:20+00:00monthlyhttp://cardiobrief.org/2011/08/10/a-failure-to-cooperate-wall-street-journal-looks-at-flawed-papers/2011-08-10T17:37:29+00:00monthlyhttp://cardiobrief.org/2011/08/09/new-study-finds-wide-variation-among-hospitals-in-diagnostic-yield-for-angiography/2011-08-09T15:46:12+00:00monthlyhttp://cardiobrief.org/2011/08/07/bernadine-healy-former-head-of-nih-and-american-red-cross-dead-of-a-brain-tumor/2011-08-08T20:33:21+00:00monthlyhttp://cardiobrief.org/2011/08/05/usa-today-finds-disparity-between-hospital-performance-and-public-perception/2011-08-05T17:40:28+00:00monthlyhttp://cardiobrief.org/2011/08/04/easy-come-easy-go-esc-to-review-dronedarones-role-in-af-guidelines/2011-08-07T23:58:34+00:00monthlyhttp://cardiobrief.org/2011/08/03/pfizer-wants-to-market-otc-atorvastatin-lipitor/2011-08-04T00:21:17+00:00monthlyhttp://cardiobrief.org/2011/08/03/recommended-reading-a-critical-view-of-antioxidants/2011-08-03T20:03:02+00:00monthlyhttp://cardiobrief.org/2011/08/02/moderate-exercise-delivers-the-biggest-bang-for-the-buck/2011-08-02T13:49:30+00:00monthlyhttp://cardiobrief.org/2011/08/01/going-beyond-courage-nhlbi-funds-the-ischemia-study/2011-08-01T22:18:53+00:00monthlyhttp://cardiobrief.org/2011/07/30/us-senate-unanimously-endorses-campaign-against-atrial-fibrillation/2011-09-08T15:14:06+00:00monthlyhttp://cardiobrief.org/2011/07/29/controversial-iom-report-highly-critical-of-510k-process/2011-07-29T17:03:06+00:00monthlyhttp://cardiobrief.org/2011/07/27/astrazeneca-sets-premium-price-for-ticagrelor-brilinta/2011-07-27T22:57:29+00:00monthlyhttp://cardiobrief.org/2011/07/27/mixed-results-for-new-implantable-device-for-the-treatment-of-resistant-hypertension/2011-07-27T19:57:22+00:00monthlyhttp://cardiobrief.org/2011/07/26/study-finds-differences-in-heritability-of-coronary-and-cerebrovascular-disease/2011-07-26T21:02:03+00:00monthlyhttp://cardiobrief.org/2011/07/25/adding-hba1c-measurements-improves-cv-risk-prediction-in-diabetics/2011-07-25T21:19:47+00:00monthlyhttp://cardiobrief.org/2011/07/24/appraise-2-dashes-hope-of-adding-anticoagulant-to-antiplatelet-therapy-in-acs/2011-07-24T23:07:14+00:00monthlyhttp://cardiobrief.org/2011/07/23/less-may-be-more-but-stents-are-neither-good-nor-bad/2012-01-21T00:23:49+00:00monthlyhttp://cardiobrief.org/2011/07/21/fda-and-ema-issue-updates-on-dronedarone-varenicline-and-pioglitazone/2011-07-21T19:27:32+00:00monthlyhttp://cardiobrief.org/2011/07/20/sapien-transcatheter-heart-valve-receives-strong-support-from-fda-advisory-panel/2011-07-25T20:20:27+00:00monthlyhttp://cardiobrief.org/2011/07/20/astrazeneca-ticagrelor-brilinta-gains-fda-approval/2011-07-20T21:52:03+00:00monthlyhttp://cardiobrief.org/2011/07/18/study-suggests-possibility-that-cetp-inhibitors-may-improve-glycemic-control/2011-07-18T21:27:21+00:00monthlyhttp://cardiobrief.org/2011/07/18/fda-releases-briefing-documents-for-advisory-panel-on-the-edwards-sapien-transcatheter-aortic-valve-implant/2011-07-18T13:46:50+00:00monthlyhttp://cardiobrief.org/2011/07/14/the-mark-midei-cases-patient-a/2011-07-14T21:29:27+00:00monthlyhttp://cardiobrief.org/2011/07/13/maryland-revokes-mark-mideis-medical-license/2011-07-13T22:00:01+00:00monthlyhttp://cardiobrief.org/2011/07/13/therapeutic-hypothermia-network-benefits-cardiac-arrest-patients/2011-07-13T17:55:38+00:00monthlyhttp://cardiobrief.org/2011/07/12/study-finds-sodium-potassium-ratio-strongly-tied-to-mortality-and-cv-disease/2011-07-12T15:23:54+00:00monthlyhttp://cardiobrief.org/2011/07/11/oat-trial-had-little-impact-on-clinical-practice/2011-07-11T20:07:25+00:00monthlyhttp://cardiobrief.org/2011/07/09/guest-post-creepy-invasion-of-pharma-into-patient-targeted-social-media-space/2011-07-15T20:33:40+00:00monthlyhttp://cardiobrief.org/2011/07/08/esc-congress-in-paris-hot-lines-and-clinical-trial-updates/2011-07-08T21:05:09+00:00monthlyhttp://cardiobrief.org/2011/07/07/guest-post-multaqs-off-again-on-again-then-off-again-ride/2011-07-07T18:29:29+00:00monthlyhttp://cardiobrief.org/2011/07/07/dronedarone-multaq-study-for-permanent-af-stopped-early/2011-07-07T15:54:47+00:00monthlyhttp://cardiobrief.org/2011/07/07/ascend-hf-no-harm-or-benefit-with-nesiritide/2011-07-07T14:49:16+00:00monthlyhttp://cardiobrief.org/2010/11/14/aha-ascend-trial-finally-resolves-the-nesiritide-conroversy/2011-07-07T13:42:51+00:00monthlyhttp://cardiobrief.org/2011/07/06/lower-sudden-cardiac-death-rates-observed-in-women-with-healthy-lifestyles/2011-07-06T18:54:05+00:00monthlyhttp://cardiobrief.org/2011/07/05/comment-acc-circling-the-wagons-once-again/2011-07-05T21:49:19+00:00monthlyhttp://cardiobrief.org/2011/07/05/ncdr-study-in-jama-only-half-of-nonacute-pcis-deemed-appropriate/2011-08-17T01:01:51+00:00monthlyhttp://cardiobrief.org/2011/07/04/meta-analysis-finds-increased-cv-risk-associated-with-varenicline-chantix/2011-07-04T18:57:42+00:00monthlyhttp://cardiobrief.org/2011/07/01/rivaroxaban-xarelto-gains-first-fda-approval-for-dvt-prevention/2011-07-01T19:52:24+00:00monthlyhttp://cardiobrief.org/2011/07/01/the-voice-of-the-patient-time-to-bring-out-the-muzzle/2011-07-02T02:56:24+00:00monthlyhttp://cardiobrief.org/2011/06/29/very-little-new-light-shed-on-the-archives-meditation-fiasco/2011-06-30T23:35:30+00:00monthlyhttp://cardiobrief.org/2011/06/27/archives-decides-at-last-minute-not-to-publish-a-scheduled-paper/2011-07-07T20:54:34+00:00monthlyhttp://cardiobrief.org/2011/06/28/new-concerns-raised-about-withdrawn-archives-meditation-paper/2011-07-01T04:25:25+00:00monthlyhttp://cardiobrief.org/2011/06/27/asprin-dosage-in-us-may-explain-disparity-in-ticagrelor-results-in-plato/2011-06-27T19:12:06+00:00monthlyhttp://cardiobrief.org/2011/06/25/diabetes-growth-termed-a-rising-global-hazard/2011-06-25T13:30:32+00:00monthlyhttp://cardiobrief.org/2011/06/25/limited-benefit-found-for-early-aggressive-management-of-diabetes/2011-06-25T13:30:16+00:00monthlyhttp://cardiobrief.org/2011/06/24/fda-recommends-more-conservative-dosing-of-esas/2011-06-24T16:46:54+00:00monthlyhttp://cardiobrief.org/2011/06/23/pundits-declare-victory-in-anticoagulant-contest-but-its-not-over-yet/2011-06-23T22:32:44+00:00monthlyhttp://cardiobrief.org/2011/06/22/apixaban-eliquis-meets-primary-endpoint-in-aristotle/2011-06-22T22:12:05+00:00monthlyhttp://cardiobrief.org/2011/06/22/jama-skeptical-perspectives-on-consumer-cardiac-tests-and-vitamin-d/2011-06-22T22:55:37+00:00monthlyhttp://cardiobrief.org/2011/06/21/meta-analysis-examines-risk-of-diabetes-associated-with-statins/2011-06-24T17:36:03+00:00monthlyhttp://cardiobrief.org/2011/06/21/study-finds-critical-delay-in-most-mi-patients-transferred-for-primary-pci/2011-06-21T21:03:01+00:00monthlyhttp://cardiobrief.org/2011/06/16/fda-says-varenicline-chantix-may-increase-risk-of-cv-events/2011-06-16T18:27:01+00:00monthlyhttp://cardiobrief.org/2011/06/16/fda-says-pioglitazone-use-is-linked-to-bladder-cancer/2011-06-16T15:04:17+00:00monthlyhttp://cardiobrief.org/2011/06/15/nejm-fda-officials-explain-the-new-simvastatin-label/2011-06-16T12:55:59+00:00monthlyhttp://cardiobrief.org/2011/06/15/twice-a-stent-pioneer-jj-abandons-the-stent-market/2011-06-15T17:42:44+00:00monthlyhttp://cardiobrief.org/2011/06/14/crt-for-hf-patients-with-moderately-prolonged-qrs-interval-unethical/2011-06-22T20:55:12+00:00monthlyhttp://cardiobrief.org/2011/06/13/increased-mortality-found-in-mi-patients-during-ambulance-diversion/2011-06-13T15:07:54+00:00monthlyhttp://cardiobrief.org/2011/06/10/a-new-biomarker-from-the-lungs/2011-06-10T17:34:06+00:00monthlyhttp://cardiobrief.org/2011/06/09/pioglitazone-actos-suspended-in-france-over-cancer-concerns/2011-06-20T16:33:52+00:00monthlyhttp://cardiobrief.org/2011/06/08/sharp-results-published-in-lancet/2011-06-11T23:01:46+00:00monthlyhttp://cardiobrief.org/2011/06/08/fda-recommends-limiting-usage-of-high-dose-simvastatin/2011-06-08T21:16:41+00:00monthlyhttp://cardiobrief.org/2011/06/07/fda-sets-july-20-date-for-advisory-panel-on-sapien-transcatheter-aortic-valve/2011-06-08T00:34:32+00:00monthlyhttp://cardiobrief.org/2011/06/06/smoking-found-to-be-potent-risk-factor-for-sympatomatic-pad/2011-06-07T13:35:40+00:00monthlyhttp://cardiobrief.org/2011/06/07/propublica-investigates-heart-check-america/2011-06-07T14:42:09+00:00monthlyhttp://cardiobrief.org/2011/06/05/partner-a-results-published-in-nejm/2011-06-05T23:46:07+00:00monthlyhttp://cardiobrief.org/2011/06/03/understanding-risk-tricky-business/2011-06-03T15:59:07+00:00monthlyhttp://cardiobrief.org/2011/06/02/fda-arbs-dont-increase-risk-of-cancer/2011-06-02T19:06:51+00:00monthlyhttp://cardiobrief.org/2011/06/02/cdc-death-rates-for-heart-disease-and-cancer-converge/2011-06-02T21:15:34+00:00monthlyhttp://cardiobrief.org/2011/06/02/small-study-suggests-possible-benefits-of-fish-oil-supplements-for-pci-patients/2011-06-02T15:39:08+00:00monthlyhttp://cardiobrief.org/2011/06/01/more-questions-raised-about-biotroniks-relationships-with-cardiologists/2011-06-01T18:39:08+00:00monthlyhttp://cardiobrief.org/2011/05/31/biomarkers-dont-believe-the-hype/2011-05-31T20:17:03+00:00monthlyhttp://cardiobrief.org/2011/05/28/comment-abbott-costello-weigh-in-on-niacin/2011-05-29T16:03:17+00:00monthlyhttp://cardiobrief.org/2011/05/28/national-lipid-association-aim-high-results-disappointing-but-prescribing-practices-should-not-change/2011-05-29T01:06:34+00:00monthlyhttp://cardiobrief.org/2011/05/26/nhlbi-stops-the-aim-high-trial-of-niacin/2011-05-28T20:41:21+00:00monthlyhttp://cardiobrief.org/2011/05/25/senate-report-uncovers-sanofi-attempts-to-stifle-generic-lovenox/2011-05-26T04:26:27+00:00monthlyhttp://cardiobrief.org/2011/05/25/fda-approves-xience-nano-for-small-vessels/2011-05-25T13:04:26+00:00monthlyhttp://cardiobrief.org/2011/05/24/pictures-at-an-exhibition/2011-05-24T20:50:48+00:00monthlyhttp://cardiobrief.org/2011/05/24/copeptin-may-help-predict-cv-death-in-elderly-hf-patients/2011-05-24T20:10:15+00:00monthlyhttp://cardiobrief.org/2011/05/24/new-onset-af-linked-to-increase-in-death-and-cv-events/2011-05-24T20:09:50+00:00monthlyhttp://cardiobrief.org/2011/05/23/what-is-the-impact-of-screening-low-risk-patients-with-ct-angiography/2011-05-23T21:11:36+00:00monthlyhttp://cardiobrief.org/2011/05/23/eplerenone-found-to-also-reduce-af-in-hf-patients/2011-05-23T14:01:16+00:00monthlyhttp://cardiobrief.org/2011/05/21/annuloplasty-rings-edwards-and-the-fda-more-details-emerge/2011-05-21T23:29:25+00:00monthlyhttp://cardiobrief.org/2011/05/19/fda-panel-delivers-mixed-verdict-on-trilipix-fenofibrate/2011-05-19T21:31:33+00:00monthlyhttp://cardiobrief.org/2011/05/19/propublica-medical-schools-plug-holes-in-conflict-of-interest-policies/2011-05-19T18:21:29+00:00monthlyhttp://cardiobrief.org/2011/05/18/fda-announces-details-of-severe-new-restrictions-on-rosiglitazone/2011-05-18T19:03:21+00:00monthlyhttp://cardiobrief.org/2011/05/17/part-1-the-national-lipid-association-and-the-fh-guidelines/2011-05-17T21:01:52+00:00monthlyhttp://cardiobrief.org/2011/05/17/part-2-the-national-lipid-association-and-industry/2011-06-24T23:40:45+00:00monthlyhttp://cardiobrief.org/2011/05/17/part-3-the-nla-responds-to-questions/2011-05-17T20:07:34+00:00monthlyhttp://cardiobrief.org/2011/05/17/the-curse-of-the-egyptian-mummy-coronary-artery-disease/2011-05-17T15:46:39+00:00monthlyhttp://cardiobrief.org/2011/05/17/fda-reviewers-scrutinize-accord-and-trilipix/2011-05-17T13:41:30+00:00monthlyhttp://cardiobrief.org/2011/05/16/sleep-deprivation-and-the-cardiac-surgeon/2011-05-16T21:15:43+00:00monthlyhttp://cardiobrief.org/2011/05/13/propublica-cardiac-society-draws-bulk-of-funding-from-stent-makers/2011-05-13T18:42:52+00:00monthlyhttp://cardiobrief.org/2011/05/12/tavi-stroke-more-details-surface-about-partner-a/2011-05-12T15:14:51+00:00monthlyhttp://cardiobrief.org/2011/05/10/study-finds-little-effect-of-courage-on-adoption-of-optimal-medical-therapy/2011-05-10T20:05:17+00:00monthlyhttp://cardiobrief.org/2011/05/10/trial-reveals-no-benefit-and-some-concerns-with-epo-after-primary-pci/2011-05-11T13:03:20+00:00monthlyhttp://cardiobrief.org/2011/05/09/short-term-nsaid-use-linked-to-increased-cv-risk/2011-05-09T21:14:45+00:00monthlyhttp://cardiobrief.org/2011/05/09/higher-periprocedural-risk-of-stroke-found-in-women-undergoing-carotid-stenting/2011-05-09T15:05:11+00:00monthlyhttp://cardiobrief.org/2011/05/06/acc-ceo-jack-lewin-provides-the-argument-against-industry-money/2011-05-09T12:57:09+00:00monthlyhttp://cardiobrief.org/2011/05/05/financial-ties-bind-medical-societies-to-drug-and-device-makers/2011-05-06T03:25:48+00:00monthlyhttp://cardiobrief.org/2011/05/05/the-heart-rhythm-society-responds-to-propublica%e2%80%99s-questions/2011-05-06T02:54:16+00:00monthlyhttp://cardiobrief.org/2011/05/05/heart-society%e2%80%99s-tip-sheets-fail-to-mention-risks/2011-05-06T02:50:53+00:00monthlyhttp://cardiobrief.org/2011/05/05/the-acc-counts-down-to-launch-of-new-satellites/2011-05-05T20:50:50+00:00monthlyhttp://cardiobrief.org/2011/05/05/5-patients-infected-with-hepatitis-c-while-undergoing-mpi/2011-05-05T14:51:49+00:00monthlyhttp://cardiobrief.org/2011/05/04/accme-seeks-to-hide-drug-company-disclosures-in-the-fine-print/2011-05-04T20:43:07+00:00monthlyhttp://cardiobrief.org/2011/05/04/study-estimates-that-af-adds-26-billion-to-yearly-us-healthcare-costs/2011-05-04T18:44:34+00:00monthlyhttp://cardiobrief.org/2011/05/04/study-challenges-efforts-to-lower-salt-in-the-general-population/2011-05-03T21:54:35+00:00monthlyhttp://cardiobrief.org/2011/05/03/cabg-takes-the-brunt-of-decline-in-revascularization-procedures/2011-05-03T21:05:35+00:00monthlyhttp://cardiobrief.org/2011/05/03/what-i-would-have-done-with-osama-bin-laden/2011-05-03T19:54:19+00:00monthlyhttp://cardiobrief.org/2011/05/03/pradaxa-dabigatran-off-to-a-strong-start/2011-05-03T15:19:58+00:00monthlyhttp://cardiobrief.org/2011/05/02/standard-guidelines-compared-to-individualized-guidelines/2011-05-02T21:41:47+00:00monthlyhttp://cardiobrief.org/2011/05/02/fda-approves-linagliptin-tradjenta-a-new-dpp-4-inhibitor/2011-05-02T20:27:16+00:00monthlyhttp://cardiobrief.org/2011/05/01/pennsylvania-hopsital-at-center-of-controversy-had-very-high-stent-volume/2011-05-02T00:50:24+00:00monthlyhttp://cardiobrief.org/2011/04/28/cardiologists-report-325000-median-compensation-in-survey/2011-04-28T20:15:14+00:00monthlyhttp://cardiobrief.org/2011/04/27/large-meta-analysis-finds-no-link-between-arbs-and-risk-of-mi/2011-04-27T19:42:57+00:00monthlyhttp://cardiobrief.org/2011/04/27/scientific-fraud-found-in-wayne-alexanders-research-group-at-emory/2011-05-02T21:04:06+00:00monthlyhttp://cardiobrief.org/2011/04/26/drug-eluting-stents-add-1-5-billion-per-year-to-medicare-costs/2011-04-26T17:23:46+00:00monthlyhttp://cardiobrief.org/2011/04/25/third-generation-paclitaxel-eluting-platinum-chromium-coronary-stent-approved-in-us/2011-04-25T19:33:56+00:00monthlyhttp://cardiobrief.org/2011/04/25/acc-aha-publish-expert-consensus-document-on-hypertension-in-the-elderly/2011-04-25T19:12:33+00:00monthlyhttp://cardiobrief.org/2011/04/24/tracking-doctors-movements-and-prescriptions/2011-04-25T04:16:11+00:00monthlyhttp://cardiobrief.org/2011/04/22/mark-midei-gives-a-preview-of-his-defense/2011-04-22T23:06:39+00:00monthlyhttp://cardiobrief.org/2011/04/21/cdc-half-the-us-now-protected-by-comprehensive-smoke-free-laws/2011-04-21T18:47:03+00:00monthlyhttp://cardiobrief.org/2011/04/21/the-impossible-dream-a-scientific-committee-free-of-conlicts-of-interest/2011-04-21T16:05:36+00:00monthlyhttp://cardiobrief.org/2011/04/20/new-whi-analysis-links-calcium-supplements-to-cv-risk/2011-04-20T17:57:20+00:00monthlyhttp://cardiobrief.org/2011/04/19/50k-the-price-for-a-vip-dinner-for-2-with-the-cleveland-clinic-ceo/2011-04-20T12:55:20+00:00monthlyhttp://cardiobrief.org/2011/04/19/non-evidence-based-icd-implants-the-debate-continues/2011-04-19T20:26:43+00:00monthlyhttp://cardiobrief.org/2011/04/18/100-is-the-new-150-aha-lowers-optimal-triglyceride-level/2011-04-18T20:16:12+00:00monthlyhttp://cardiobrief.org/2011/04/17/evidence-the-weak-link-of-evidence-based-medicine/2011-08-23T10:42:11+00:00monthlyhttp://cardiobrief.org/2011/04/13/ny-times-magazine-sugar-is-not-so-sweet/2011-04-15T16:46:05+00:00monthlyhttp://cardiobrief.org/2011/04/14/fda-offers-cautious-support-for-olmesartan-benicar/2011-04-14T21:46:03+00:00monthlyhttp://cardiobrief.org/2011/04/14/fda-officials-offer-explanation-for-absence-of-low-dose-dabigatran/2011-04-14T14:22:26+00:00monthlyhttp://cardiobrief.org/2011/04/13/increasing-disparity-found-in-stroke-mortality-in-europe-and-central-asia-a-period-of-rapidly-increasing-inequality-between-countries/2011-04-13T16:39:33+00:00monthlyhttp://cardiobrief.org/2011/04/12/particle-trap-reduces-harmful-diesel-emissions/2011-04-12T15:45:15+00:00monthlyhttp://cardiobrief.org/2011/04/11/phenterminetopiramate-combination-yields-significant-weight-loss/2011-12-30T14:45:57+00:00monthlyhttp://cardiobrief.org/2011/04/11/2-studies-try-to-improve-risk-prediction-for-kidney-disease-progression/2011-04-11T21:28:04+00:00monthlyhttp://cardiobrief.org/2011/04/11/acc-satellites-meet-the-new-boss-same-as-the-old-boss/2011-04-11T12:40:59+00:00monthlyhttp://cardiobrief.org/2011/04/09/harlem-hospitals-former-chief-of-cardiology-sues-new-york-city/2011-04-09T23:24:20+00:00monthlyhttp://cardiobrief.org/2011/04/06/big-brother-err-the-acc-is-watching-you/2011-04-07T12:56:03+00:00monthlyhttp://cardiobrief.org/2011/04/05/at-the-close-of-scientific-sessions-acc-announces-the-end-of-current-model-of-satellite-symposia/2011-04-05T22:41:35+00:00monthlyhttp://cardiobrief.org/2011/04/05/magellan-higher-bleeding-rates-cloud-rivaroxabans-effect-in-vte-prevention-in-acute-medical-population/2011-04-05T15:14:59+00:00monthlyhttp://cardiobrief.org/2011/04/04/mitraclip-compared-to-surgery-in-everest-ii/2011-04-05T04:01:04+00:00monthlyhttp://cardiobrief.org/2011/04/04/rival-trial-radial-vs-femoral-access/2011-04-04T20:24:16+00:00monthlyhttp://cardiobrief.org/2011/04/04/stich-illuminates-cabg-in-heart-failure-finally/2011-04-04T16:44:42+00:00monthlyhttp://cardiobrief.org/2011/04/04/precombat-explores-pci-versus-cabg-for-left-main-disease/2011-04-04T16:15:55+00:00monthlyhttp://cardiobrief.org/2011/04/03/partner-a-tavr-noninferior-to-surgery-but-stroke-may-be-a-problem/2011-11-01T23:25:29+00:00monthlyhttp://cardiobrief.org/2011/04/03/2-year-outcomes-of-the-resolute-all-comers-trial/2011-04-03T18:22:32+00:00monthlyhttp://cardiobrief.org/2011/04/03/partner-b-substudy-examines-cost-effectiveness-of-tavr/2011-04-03T17:55:50+00:00monthlyhttp://cardiobrief.org/2011/04/02/reloading-the-matrix-doris-taylor-is-growing-new-hearts/2011-06-18T21:13:23+00:00monthlyhttp://cardiobrief.org/2011/04/01/laissez-le-bon-temps-roulez/2011-04-01T22:14:53+00:00monthlyhttp://cardiobrief.org/2011/03/30/fda-warns-against-repackaging-dabigatran/2011-07-19T20:02:57+00:00monthlyhttp://cardiobrief.org/2011/03/31/an-embargo-becomes-a-public-relations-tool/2011-03-31T16:24:00+00:00monthlyhttp://cardiobrief.org/2011/03/29/conflicts-of-interest-in-cardiovascular-guidelines/2011-03-29T21:24:57+00:00monthlyhttp://cardiobrief.org/2011/03/29/protect-ii-who-will-protect-us-from-the-protectors/2011-03-29T19:27:19+00:00monthlyhttp://cardiobrief.org/2011/03/28/guest-post-supermarket-chain-gawking-quaker-products-free-cholesterol-screening/2011-03-29T01:59:42+00:00monthlyhttp://cardiobrief.org/2010/12/10/spinning-out-of-control-another-look-at-the-protect-ii-press-release/2011-03-29T00:38:16+00:00monthlyhttp://cardiobrief.org/2011/03/28/updated-unstable-anginanstemi-guidelines-released-by-acc-aha/2011-03-28T20:18:19+00:00monthlyhttp://cardiobrief.org/2011/03/28/fda-approves-medtronic-protecta-icds-and-crt-ds/2011-03-28T19:12:59+00:00monthlyhttp://cardiobrief.org/2011/03/25/fda-approves-2-new-cardiac-resynchronization-therapy-pacemaker-systems-from-medtronic/2011-03-25T15:59:26+00:00monthlyhttp://cardiobrief.org/2011/03/24/study-finds-pioglitazone-prevents-progression-to-diabetes/2011-03-24T14:53:56+00:00monthlyhttp://cardiobrief.org/2011/03/24/merck-abandons-development-of-factor-xa-inhibitor-betrixaban/2011-03-24T13:58:58+00:00monthlyhttp://cardiobrief.org/2011/03/22/protect-compares-unfractionated-heparin-and-dalteparin-in-critically-ill-patients/2011-03-23T18:40:08+00:00monthlyhttp://cardiobrief.org/2011/03/22/fibrate-prescriptions-a-tale-of-two-countries/2011-03-23T21:20:06+00:00monthlyhttp://cardiobrief.org/2011/03/22/good-news-and-bad-news-about-physical-and-sexual-activity-and-cardiac-events/2011-03-23T18:36:47+00:00monthlyhttp://cardiobrief.org/2011/03/23/the-french-set-a-new-roadblock-for-ticagrelor/2011-03-23T18:19:36+00:00monthlyhttp://cardiobrief.org/2011/03/23/new-protocol-identifies-low-risk-chest-pain-patients/2011-03-23T17:30:16+00:00monthlyhttp://cardiobrief.org/2011/03/22/study-explores-lowering-the-troponin-diagnostic-threshold/2011-03-23T09:42:26+00:00monthlyhttp://cardiobrief.org/2011/03/22/aha-releases-new-recommendations-for-management-of-acute-vte/2011-03-22T15:37:36+00:00monthlyhttp://cardiobrief.org/2011/03/21/stent-company-sues-investigator-over-trial-conduct/2011-03-21T18:59:20+00:00monthlyhttp://cardiobrief.org/2011/03/18/lilly-and-daiichi-sankyo-pull-the-trigger-and-kill-prasugrel-study/2011-03-18T22:29:52+00:00monthlyhttp://cardiobrief.org/2011/03/17/meta-analysis-of-observational-studies-finds-worse-outcomes-for-rosiglitazone-compared-to-pioglitazone/2011-03-17T23:21:42+00:00monthlyhttp://cardiobrief.org/2011/03/17/small-study-may-help-revive-hope-for-stem-cell-therapy/2011-03-17T21:14:09+00:00monthlyhttp://cardiobrief.org/2011/03/17/acc-and-medpage-will-provide-enhanced-news-from-20-cardiology-meetings/2011-03-17T14:40:55+00:00monthlyhttp://cardiobrief.org/2011/03/16/syntax-quality-of-life-substudy-finds-small-benefit-for-cabg-in-angina-relief/2011-03-16T21:56:26+00:00monthlyhttp://cardiobrief.org/2011/03/15/gravitas-published-who-gets-to-weigh-in-on-the-results/2011-03-17T18:17:05+00:00monthlyhttp://cardiobrief.org/2011/03/14/taking-medical-advice-from-peggy-fleming/2011-03-14T22:22:59+00:00monthlyhttp://cardiobrief.org/2011/03/14/aha-offers-qualified-endorsement-of-weight-loss-surgery/2011-03-14T20:48:48+00:00monthlyhttp://cardiobrief.org/2011/03/10/obesity-and-cardiovascular-risk-does-size-matter/2011-03-12T00:00:56+00:00monthlyhttp://cardiobrief.org/2011/03/10/howard-bauchner-to-replace-catherine-deangelis-as-jama-editor/2011-03-10T17:41:58+00:00monthlyhttp://cardiobrief.org/2011/03/10/olmesartan-helps-prevent-microalbuminuria-but-a-troubling-question-persists/2011-03-10T16:59:10+00:00monthlyhttp://cardiobrief.org/2011/03/09/active-i-examines-role-for-irbesartan-in-af-patients/2011-03-10T14:25:04+00:00monthlyhttp://cardiobrief.org/2011/03/09/guest-post-the-return-of-the-mysterious-disappearing-exploding-icd/2011-03-09T22:50:23+00:00monthlyhttp://cardiobrief.org/2011/03/08/european-study-suggests-hdl-may-protect-against-colon-cancer/2011-03-08T19:55:32+00:00monthlyhttp://cardiobrief.org/2011/03/07/meta-analysis-finds-mediterranean-diet-helps-fight-metabolic-syndrome/2011-03-07T21:22:25+00:00monthlyhttp://cardiobrief.org/2011/03/04/first-aftershocks-continue-to-shake-up-western-pennsylvania-cardiology/2011-03-04T20:55:57+00:00monthlyhttp://cardiobrief.org/2011/03/03/pennsylvania-hospital-141-patients-received-unnecessary-stents/2011-03-03T18:12:25+00:00monthlyhttp://cardiobrief.org/2011/03/02/5-year-followup-of-accord-still-no-support-for-intensive-glucose-lowering/2011-03-02T22:53:19+00:00monthlyhttp://cardiobrief.org/2011/03/01/cv-patients-without-hypertension-benefit-from-antihypertensive-therapy/2011-03-01T22:53:00+00:00monthlyhttp://cardiobrief.org/2011/03/01/cv-device-trials-still-fail-to-include-more-women/2011-03-01T22:49:06+00:00monthlyhttp://cardiobrief.org/2011/03/01/guest-post-examining-an-ad-for-a-platelet-inhibition-test/2011-03-01T03:44:17+00:00monthlyhttp://cardiobrief.org/2011/02/28/what-is-the-role-of-cv-screening-tests-in-medicine-and-legislation/2011-02-28T21:28:00+00:00monthlyhttp://cardiobrief.org/2011/02/27/the-acc-wants-you-to-know-that-nothing-is-rotten-in-the-state-of-maryland/2011-02-27T21:30:30+00:00monthlyhttp://cardiobrief.org/2011/02/25/fda-approves-azilsartan-medoxomil-edarbi-for-high-blood-pressure/2011-02-26T20:09:43+00:00monthlyhttp://cardiobrief.org/2011/02/24/study-probes-bmi-associated-risk-in-asia/2011-02-24T22:03:11+00:00monthlyhttp://cardiobrief.org/2011/02/23/air-pollution-and-cocaine-among-mi-triggers-analyzed-in-lancet-study/2011-02-23T21:08:05+00:00monthlyhttp://cardiobrief.org/2011/02/23/high-pacemaker-insertion-rate-observed-after-corevalve-tavi-implantation/2011-02-23T21:00:23+00:00monthlyhttp://cardiobrief.org/2011/02/22/study-finds-nitroglycerin-improves-bone-density/2011-02-22T23:13:57+00:00monthlyhttp://cardiobrief.org/2011/02/22/study-links-stent-thrombosis-to-circadian-variation/2011-02-22T15:24:11+00:00monthlyhttp://cardiobrief.org/2011/02/17/one-quarter-of-us-adults-45-and-over-taking-statins/2011-02-23T06:14:57+00:00monthlyhttp://cardiobrief.org/2011/02/16/ron-waksman-paper-on-novel-cad-test-retracted/2011-02-16T22:10:08+00:00monthlyhttp://cardiobrief.org/2011/02/16/study-sheds-light-on-racial-disparities-in-hospital-readmissions/2011-02-16T13:52:39+00:00monthlyhttp://cardiobrief.org/2011/02/15/aha-releases-updated-guidelines-for-the-prevention-of-cv-disease-in-women/2011-02-15T16:23:35+00:00monthlyhttp://cardiobrief.org/2011/02/15/crt-found-beneficial-in-less-severe-heart-failure-patients/2011-02-14T22:15:05+00:00monthlyhttp://cardiobrief.org/2011/02/11/scast-trial-provides-no-support-for-blood-pressure-lowering-in-acute-stroke/2011-02-14T21:51:57+00:00monthlyhttp://cardiobrief.org/2011/02/14/af-guidelines-updated-to-incorporate-dabigatran/2011-02-14T21:51:23+00:00monthlyhttp://cardiobrief.org/2011/02/12/featured-comment-on-the-ethical-code-for-federal-employees/2011-02-13T00:45:07+00:00monthlyhttp://cardiobrief.org/2011/02/09/trial-finds-benefit-in-wireless-pulmonary-artery-monitoring-in-hf/2011-02-11T07:33:19+00:00monthlyhttp://cardiobrief.org/2011/02/10/apixaban-better-than-aspirin-for-stroke-prevention-in-af-patients-unable-to-take-warfarin/2011-02-10T16:16:39+00:00monthlyhttp://cardiobrief.org/2011/02/09/guest-post-retraction-reveals-downfall-of-company-where-ron-waksman-consulted/2011-02-09T22:01:00+00:00monthlyhttp://cardiobrief.org/2011/02/09/acc-late-breakers-to-include-partner-a-everest-ii-stich-magellan/2011-02-09T17:45:46+00:00monthlyhttp://cardiobrief.org/2011/02/08/biomarker-levels-post-cabg-strongly-linked-to-mortality/2011-02-08T21:16:02+00:00monthlyhttp://cardiobrief.org/2011/02/08/fda-approves-first-pacemaker-designed-for-use-with-mri/2011-02-08T20:37:22+00:00monthlyhttp://cardiobrief.org/2011/02/07/webmd-the-800-pound-gorilla-in-the-room/2011-02-07T23:01:12+00:00monthlyhttp://cardiobrief.org/2011/02/04/fda-sets-july-deadline-for-decision-on-ticagrelor-brilinta/2011-02-04T23:39:39+00:00monthlyhttp://cardiobrief.org/2011/02/04/some-things-dont-go-better-with-coke/2011-02-04T20:02:52+00:00monthlyhttp://cardiobrief.org/2011/02/03/lancet-papers-outline-worldwide-trends-in-obesity-hypertension-and-cholesterol/2011-02-04T19:04:42+00:00monthlyhttp://cardiobrief.org/2011/02/03/guest-post-how-to-question-the-research-question/2011-02-03T19:08:04+00:00monthlyhttp://cardiobrief.org/2011/02/02/heart-failure-can-be-fixed-just-like-a-broken-leg-for-50-million/2011-02-05T13:30:28+00:00monthlyhttp://cardiobrief.org/2011/02/01/cdc-details-the-persistent-problem-of-hypertension-and-elevated-ldl-in-the-us/2011-02-02T01:37:23+00:00monthlyhttp://cardiobrief.org/2011/02/01/new-guidelines-lend-more-support-for-carotid-stenting/2011-02-01T19:45:17+00:00monthlyhttp://cardiobrief.org/2011/01/31/women-and-younger-patients-may-be-at-higher-risk-for-sprint-fidelis-failure/2011-01-31T21:47:37+00:00monthlyhttp://cardiobrief.org/2010/12/22/guest-post-survey-or-advertisement/2011-02-01T00:47:06+00:00monthlyhttp://cardiobrief.org/2011/01/28/justice-department-files-new-suit-against-boston-scientific/2011-01-28T19:11:02+00:00monthlyhttp://cardiobrief.org/2011/01/27/hps-results-suggest-baseline-crp-doesnt-predict-statin-efficacy/2011-01-28T18:36:42+00:00monthlyhttp://cardiobrief.org/about-2/2011-12-30T15:51:43+00:00weekly0.6http://cardiobrief.org/2011/01/26/end-of-an-era-eugene-braunwald-steps-down-marc-sabatine-assumes-chair-of-timi-group/2011-01-27T22:11:38+00:00monthlyhttp://cardiobrief.org/2011/01/26/jama-study-finds-declining-stroke-rate-after-cabg/2011-01-26T19:26:11+00:00monthlyhttp://cardiobrief.org/2011/01/25/inappropriate-icd-shocks-linked-to-increased-mortality/2011-10-30T11:59:46+00:00monthlyhttp://cardiobrief.org/2011/01/25/new-study-finds-hydrochlorothiazide-inferior-to-all-other-bp-drugs/2011-01-25T16:05:12+00:00monthlyhttp://cardiobrief.org/2011/01/24/aha-estimates-cost-of-heart-disease-will-triple-by-2030/2011-01-24T19:42:19+00:00monthlyhttp://cardiobrief.org/2011/01/21/heart-rhythm-society-advising-doj-in-investigation-of-icd-implants/2012-01-30T09:47:05+00:00monthlyhttp://cardiobrief.org/2011/01/20/guest-post-prevention-magazine-pushes-high-tech-non-evidence-based-heart-screening-more-than-basic-prevention/2011-01-21T02:28:00+00:00monthlyhttp://cardiobrief.org/2011/01/20/braunwald-vorapaxar-problem-based-on-intracranial-bleeding-in-patients-with-history-of-stroke/2011-01-20T16:27:08+00:00monthlyhttp://cardiobrief.org/2011/01/19/guest-post-what-prospect-doesnt-tell-us/2011-01-19T22:37:06+00:00monthlyhttp://cardiobrief.org/2011/01/19/review-raises-questions-about-statins-for-primary-prevention/2011-01-20T01:25:57+00:00monthlyhttp://cardiobrief.org/2011/01/18/study-supports-a-new-enhanced-form-of-cpr/2011-01-19T18:07:48+00:00monthlyhttp://cardiobrief.org/2011/01/14/sanofi-aventis-provides-more-details-about-multaq-letter/2011-01-14T18:35:36+00:00monthlyhttp://cardiobrief.org/2011/01/13/sanofi-aventis-to-inform-doctors-about-liver-transplants-in-2-patients-taking-multaq-dronedarone/2011-01-14T18:35:10+00:00monthlyhttp://cardiobrief.org/2011/01/14/fda-warns-about-severe-liver-injury-associated-with-multaq-dronedarone/2011-01-14T17:05:42+00:00monthlyhttp://cardiobrief.org/2011/01/13/mercks-thrombin-receptor-antagonist-suffers-major-setback/2011-01-13T16:11:09+00:00monthlyhttp://cardiobrief.org/2011/01/13/why-do-military-doctors-have-stricter-rules-than-other-doctors/2011-02-12T16:02:25+00:00monthlyhttp://cardiobrief.org/2011/01/12/researchers-shed-new-light-on-hdl-cholesterol/2011-01-12T23:13:48+00:00monthlyhttp://cardiobrief.org/2011/01/11/large-meta-analysis-explores-cardiovascular-safety-of-nsaids/2011-01-12T22:02:36+00:00monthlyhttp://cardiobrief.org/2011/01/11/candesartan-beats-losartan-in-swedish-hf-registry/2011-01-11T22:08:43+00:00monthlyhttp://cardiobrief.org/2011/01/10/worlds-first-drug-eluting-bioresorbable-stent-gains-ce-mark-approval/2011-01-10T15:26:30+00:00monthlyhttp://cardiobrief.org/2011/01/07/acc-and-hrs-downplay-data-from-their-own-registry/2011-01-07T23:32:03+00:00monthlyhttp://cardiobrief.org/2011/01/06/bevacizumab-in-breast-cancer-linked-to-increase-in-heart-failure-risk/2011-01-06T17:51:00+00:00monthlyhttp://cardiobrief.org/2011/01/05/study-finds-mixed-long-term-results-for-af-catheter-ablation/2011-01-05T23:44:05+00:00monthlyhttp://cardiobrief.org/2011/01/05/jj-submits-rivaroxaban-application-for-stroke-prevention-in-af/2011-01-05T18:04:05+00:00monthlyhttp://cardiobrief.org/2011/01/04/jama-study-finds-22-5-of-icds-implanted-without-evidence-base/2011-01-04T22:07:59+00:00monthlyhttp://cardiobrief.org/2011/01/03/plato-cabg-substudy-raises-hope-and-questions/2011-01-04T01:52:03+00:00monthlyhttp://cardiobrief.org/2011/01/03/guest-post-medicare-the-mastercard-that-keeps-on-giving/2011-01-08T17:45:41+00:00monthlyhttp://cardiobrief.org/2010/12/22/abbott-and-astrazeneca-end-efforts-to-develop-certriad-rosuvastatinfenofibric-acid/2010-12-23T00:58:13+00:00monthlyhttp://cardiobrief.org/2010/12/22/apixaban-beats-enoxaparin-for-thromboprophylaxis-after-hip-replacement/2010-12-22T21:53:34+00:00monthlyhttp://cardiobrief.org/2010/12/21/guest-post-another-highly-dubious-article-in-the-american-journal-of-cardiology/2010-12-22T15:17:40+00:00monthlyhttp://cardiobrief.org/2010/12/20/dronedarone-rate-control-and-catheter-ablation-incorporated-in-updated-af-guidelines/2010-12-21T13:58:06+00:00monthlyhttp://cardiobrief.org/2010/12/20/propublica-med-schools-flunk-at-keeping-faculty-off-pharma-speaking-circuit/2010-12-20T18:29:30+00:00monthlyhttp://cardiobrief.org/2010/12/19/cardiosource-and-medpage-today-will-collaborate-to-provide-news-coverage-of-major-cv-meetings/2010-12-19T22:08:37+00:00monthlyhttp://cardiobrief.org/2010/12/16/fda-delays-approval-of-brilinta-ticagrelor/2010-12-17T18:09:19+00:00monthlyhttp://cardiobrief.org/2010/12/17/fda-approves-cryoballoon-ablation-treatment-for-paroxysmal-af/2011-03-01T16:17:30+00:00monthlyhttp://cardiobrief.org/2010/12/15/heart-disease-and-stroke-in-2011-mortality-continues-to-decline-but-overall-burden-remains-high/2012-01-24T22:08:28+00:00monthlyhttp://cardiobrief.org/2010/12/14/dangling-doctors-in-front-of-journalists/2010-12-16T01:24:59+00:00monthlyhttp://cardiobrief.org/2010/12/13/false-positive-ct-angiogram-leads-to-heart-transplant/2010-12-29T17:56:48+00:00monthlyhttp://cardiobrief.org/2010/12/11/mideis-business-as-usual-defensethis-is-the-way-its-done/2010-12-11T23:21:51+00:00monthlyhttp://cardiobrief.org/2010/12/10/nmt-gets-plugged-not-in-a-good-way-by-ben-goldacre/2010-12-11T04:12:29+00:00monthlyhttp://cardiobrief.org/2010/12/07/protect-ii-study-of-impella-stopped-early-for-futility/2010-12-10T20:03:34+00:00monthlyhttp://cardiobrief.org/2010/12/09/cdc-demotes-stroke-to-fourth-leading-cause-of-death/2010-12-09T22:14:53+00:00monthlyhttp://cardiobrief.org/2010/12/09/meta-analysis-finds-aromatase-inhibitors-increase-risk-for-heart-disease/2010-12-09T20:04:02+00:00monthlyhttp://cardiobrief.org/2010/12/08/abbott-subsidiary-pays-41-million-penalty-for-niaspanadvicor-kickbacks/2010-12-08T23:40:40+00:00monthlyhttp://cardiobrief.org/2010/12/07/third-time-is-the-charm-fda-panel-finally-backs-an-obesity-pill/2010-12-08T09:07:24+00:00monthlyhttp://cardiobrief.org/2010/12/07/questions-raised-about-compensation-and-conflicts-at-duke/2010-12-09T21:00:17+00:00monthlyhttp://cardiobrief.org/2010/12/06/meta-analysis-daily-aspirin-reduces-cancer-deaths/2010-12-07T04:03:21+00:00monthlyhttp://cardiobrief.org/2010/12/06/senate-report-on-mark-midei-and-abbott-30-stents-in-1-day-pig-roasts-and-more/2010-12-06T18:38:40+00:00monthlyhttp://cardiobrief.org/2010/12/06/7167/2010-12-06T09:45:55+00:00monthlyhttp://cardiobrief.org/2010/12/03/the-possible-return-of-the-missing-case-report-of-the-exploding-icd/2010-12-04T01:51:31+00:00monthlyhttp://cardiobrief.org/2010/12/04/rivaroxaban-found-safe-and-effective-for-dvt/2010-12-03T23:53:58+00:00monthlyhttp://cardiobrief.org/2010/12/02/vanity-fair-article-eviscerates-globalization-of-clinical-trials/2010-12-03T01:05:33+00:00monthlyhttp://cardiobrief.org/2010/12/01/heart-failure-death-statistics-don%e2%80%99t-believe-what-you-read-on-the-internet/2010-12-02T04:43:21+00:00monthlyhttp://cardiobrief.org/2010/11/30/new-performance-measures-for-peripheral-artery-disease-issued/2010-11-30T21:54:13+00:00monthlyhttp://cardiobrief.org/2010/11/29/study-finds-no-link-between-cancer-and-antihypertensives-except-for-arb-ace-inhibitor-combo/2010-11-30T00:21:09+00:00monthlyhttp://cardiobrief.org/2010/11/29/marine-new-fish-oil-pill-slashes-high-triglycerides/2010-11-29T20:12:44+00:00monthlyhttp://cardiobrief.org/2010/11/23/greek-study-offers-reassurance-about-statin-usage-in-patients-with-abnormal-liver-tests/2010-11-27T07:03:13+00:00monthlyhttp://cardiobrief.org/2010/11/23/guest-post-of-drug-talks-deception-and-denial/2011-09-15T01:57:28+00:00monthlyhttp://cardiobrief.org/2010/11/21/sharp-a-tale-of-two-press-releases/2010-11-23T04:37:39+00:00monthlyhttp://cardiobrief.org/2010/11/20/sharp-shows-benefit-for-vytorin-in-chronic-kidney-disease/2010-11-23T05:19:58+00:00monthlyhttp://cardiobrief.org/2010/11/18/appraise-2-apixaban-in-acs-study-discontinued-due-to-increased-bleeding/2010-11-19T03:27:29+00:00monthlyhttp://cardiobrief.org/2010/11/17/aha-2010-is-history/2010-11-18T00:44:17+00:00monthlyhttp://cardiobrief.org/2010/11/17/will-this-be-the-hdl-decade-reveal-revealed-mixed-results-for-apo-a1/2011-02-11T19:53:08+00:00monthlyhttp://cardiobrief.org/2010/11/17/anacetrapib-knock-your-socks-off-effect-on-hdl-and-a-jaw-dropping-effect-on-ldl/2010-11-18T02:12:50+00:00monthlyhttp://cardiobrief.org/2010/11/16/cardioexchange-at-the-aha-a-new-voice-emerges/2010-11-16T20:36:03+00:00monthlyhttp://cardiobrief.org/2010/11/16/basket-prove-examines-stents-for-large-vessels/2010-11-16T15:20:23+00:00monthlyhttp://cardiobrief.org/2010/11/16/gravitas-no-benefit-for-clopidogrel-dosing-based-on-platelet-function-test/2010-11-16T19:45:01+00:00monthlyhttp://cardiobrief.org/2010/11/15/omega-3-fails-to-show-benefits-in-atrial-fibrillation/2010-11-15T15:28:37+00:00monthlyhttp://cardiobrief.org/2010/11/15/blast-off-rocket-af-hits-chicago/2010-11-15T14:56:38+00:00monthlyhttp://cardiobrief.org/2010/11/15/study-closes-the-book-on-pfo-closure/2012-01-16T05:36:29+00:00monthlyhttp://cardiobrief.org/2010/11/14/drinking-in-ascend-is-the-cup-half-empty-or-half-full/2010-11-15T00:59:19+00:00monthlyhttp://cardiobrief.org/2010/11/14/emphatic-support-for-eplerenone-in-nyha-class-ii-hf/2010-11-14T22:48:45+00:00monthlyhttp://cardiobrief.org/2010/11/14/icd-crt-found-beneficial-in-raft/2010-11-14T22:47:36+00:00monthlyhttp://cardiobrief.org/2010/11/14/new-lvad-shows-promise-as-bridge-to-transplant/2010-11-14T18:07:18+00:00monthlyhttp://cardiobrief.org/2010/11/14/lipstick-on-a-pig/2010-11-14T14:29:46+00:00monthlyhttp://cardiobrief.org/2010/11/13/aha-study-explores-role-of-familial-af-in-risk-of-developing-new-af/2010-11-14T00:09:19+00:00monthlyhttp://cardiobrief.org/2010/11/13/hypertension-and-global-warming-are-not-the-same-thing/2010-11-13T20:18:57+00:00monthlyhttp://cardiobrief.org/2010/11/09/in-dialysis-life-saving-care-at-great-risk-and-cost/2010-11-10T00:12:27+00:00monthlyhttp://cardiobrief.org/2010/11/09/statement-from-aha-acc-and-acg-reaffirms-use-of-ppis-with-antiplatelet-therapy/2010-11-09T16:31:25+00:00monthlyhttp://cardiobrief.org/2010/11/08/new-safety-questions-raised-about-multaq/2010-12-05T06:00:24+00:00monthlyhttp://cardiobrief.org/2010/11/07/guest-post-new-lipitor-ads-dis-exercise-healthy-diet-are-you-kidding-me/2010-11-07T23:16:23+00:00monthlyhttp://cardiobrief.org/2010/11/07/re-ly-substudy-finds-dabigatran-effective-in-secondary-stroke-prevention/2010-11-07T22:37:48+00:00monthlyhttp://cardiobrief.org/2010/11/05/meta-analysis-turns-up-mixed-results-for-vitamin-e-on-stroke-subtypes/2010-11-05T14:35:32+00:00monthlyhttp://cardiobrief.org/2010/11/03/cardiology-and-the-quran-controversy-erupts-over-paper-published-in-the-international-journal-of-cardiology/2010-11-03T20:07:16+00:00monthlyhttp://cardiobrief.org/2010/11/02/is-dabigatran-pradaxa-more-cost-effective-than-warfarin-in-af/2010-11-02T14:21:46+00:00monthlyhttp://cardiobrief.org/2010/10/31/bayer-says-rivaroxaban-meets-primary-endpoint-in-rocket-af/2010-11-02T13:20:57+00:00monthlyhttp://cardiobrief.org/2010/11/01/pradaxa-dabigatran-goes-on-sale-wednesday-november-3/2011-11-04T15:46:52+00:00monthlyhttp://cardiobrief.org/2010/10/28/anesthesiology-paper-on-cardiopulmonary-bypass-priming-retracted-200-additional-papers-under-question/2010-10-28T23:06:48+00:00monthlyhttp://cardiobrief.org/2010/10/27/meta-analysis-examines-risk-associated-with-cyp2c19-genotypes/2010-10-28T14:08:17+00:00monthlyhttp://cardiobrief.org/2010/10/26/pradaxa-dabigatran-pricing-starts-to-emerge/2012-01-17T18:13:23+00:00monthlyhttp://cardiobrief.org/2009/02/09/editorial-prasugrel-and-fda-incompetence/2010-10-26T13:33:40+00:00monthlyhttp://cardiobrief.org/2010/10/25/can-barbers-help-fight-high-blood-pressure-in-black-men/2010-10-25T22:36:33+00:00monthlyhttp://cardiobrief.org/2010/10/22/top-new-york-city-interventional-cardiologists-now-making-3-million-a-year/2010-10-22T23:25:09+00:00monthlyhttp://cardiobrief.org/2010/10/21/news-briefs-recurrent-stroke-prevention-guidelines-vernakalant-trial-suspended-gsk-investigated-generic-enoxaparin-takes-off-kaul-speaks-midei-sues/2010-10-21T20:08:50+00:00monthlyhttp://cardiobrief.org/2010/10/20/some-remaining-questions-about-dabigatran/2010-10-22T23:20:39+00:00monthlyhttp://cardiobrief.org/2010/10/19/dabigatran-gains-fda-approval/2010-11-17T15:49:05+00:00monthlyhttp://cardiobrief.org/2010/10/19/fda-issues-complete-response-letter-for-bydureon-extended-release-exenatide/2010-10-19T23:15:19+00:00monthlyhttp://cardiobrief.org/2010/10/19/fda-wont-soften-clopidogrel-omeprazole-warning/2010-10-19T21:40:53+00:00monthlyhttp://cardiobrief.org/2010/10/19/a-propublica-investigation-docs-on-pharma-payroll-have-blemished-records-limited-credentials/2010-10-19T20:00:09+00:00monthlyhttp://cardiobrief.org/2010/10/18/fda-advisors-go-easy-on-aranesp-darbepoetin-alfa/2010-10-18T22:59:49+00:00monthlyhttp://cardiobrief.org/2010/10/18/guest-post-my-journey-with-heart-failure/2010-10-20T12:29:16+00:00monthlyhttp://cardiobrief.org/2010/10/16/is-the-time-right-for-a-preprint-archive-for-clinical-trials/2010-10-16T18:32:54+00:00monthlyhttp://cardiobrief.org/2010/10/15/meta-analysis-lends-more-support-to-compression-only-cpr/2010-10-15T19:49:03+00:00monthlyhttp://cardiobrief.org/2010/10/14/trick-or-treat-fda-staff-highly-critical-of-aranesp-trial/2010-10-14T22:04:59+00:00monthlyhttp://cardiobrief.org/2010/10/13/guest-post-big-pharma-knows-your-private-health-matters/2010-10-13T18:10:17+00:00monthlyhttp://cardiobrief.org/2010/10/13/transfusions-and-cardiac-surgery-%e2%80%9ca-major-concern/2010-10-13T15:56:19+00:00monthlyhttp://cardiobrief.org/2010/10/12/heart-failure-and-resource-use-at-the-end-of-the-road/2010-10-12T20:42:38+00:00monthlyhttp://cardiobrief.org/2010/10/12/obesity-good-news-and-bad-news/2010-10-12T13:44:05+00:00monthlyhttp://cardiobrief.org/2010/10/07/the-case-of-the-exploding-icd-the-disappearing-journal-article-and-a-defensive-blogger/2010-10-11T17:03:35+00:00monthlyhttp://cardiobrief.org/2010/10/10/guest-post-why-i-wont-blog-about-heart-failure-for-us-news-world-report/2010-10-10T19:32:48+00:00monthlyhttp://cardiobrief.org/2010/10/09/the-plot-thickens-in-the-case-of-the-exploding-icd/2010-10-09T19:09:53+00:00monthlyhttp://cardiobrief.org/2010/10/08/abbott-withdraws-obesity-drug-meridia-sibutramine-from-us-market/2010-10-09T12:28:33+00:00monthlyhttp://cardiobrief.org/2010/10/07/briefs-rolofyline-fails-genome-studies-pool-data/2010-10-07T19:49:08+00:00monthlyhttp://cardiobrief.org/2010/10/06/study-finds-no-evidence-for-clopidogrel-omeprazole-interaction/2010-10-07T01:21:21+00:00monthlyhttp://cardiobrief.org/2010/10/05/briefs-genetic-expression-testing-cpr-guidelines/2010-10-05T22:30:16+00:00monthlyhttp://cardiobrief.org/2010/10/04/briefs-sleep-and-obesity-closure-device-recommendation-hypertension-in-blacks/2010-10-05T19:55:57+00:00monthlyhttp://cardiobrief.org/2010/10/01/guest-post-a-case-of-exuberance-about-a-subgroup-in-a-clinical-trial/2010-10-01T20:30:41+00:00monthlyhttp://cardiobrief.org/2010/09/30/novartis-pays-422-million-to-settle-doj-lawsuit-diovan-promotion/2010-10-01T15:34:09+00:00monthlyhttp://cardiobrief.org/2010/09/30/avandia-meridia-now-its-aranesps-turn-before-the-fda/2010-09-30T14:09:54+00:00monthlyhttp://cardiobrief.org/2010/09/29/guest-post-my-life-as-a-mom/2010-09-30T02:05:04+00:00monthlyhttp://cardiobrief.org/2010/09/28/guest-post-news-you-can-use-sex-and-your-defibrillator/2010-09-29T03:11:06+00:00monthlyhttp://cardiobrief.org/2010/09/27/carotid-endarterectomy-still-beneficial-at-10-years/2010-09-27T18:56:41+00:00monthlyhttp://cardiobrief.org/2010/09/24/tct-briefs-ees-versus-ses-peripheral-des/2010-09-24T22:41:25+00:00monthlyhttp://cardiobrief.org/2010/09/24/tct-briefs-xience-v-outperforms-taxus-at-2-years-acc-to-co-sponsor-tct-2011/2010-09-24T14:40:16+00:00monthlyhttp://cardiobrief.org/2010/09/23/fda-allows-avandia-to-remain-on-market-with-severe-restrictions/2010-12-17T21:48:08+00:00monthlyhttp://cardiobrief.org/2010/09/23/nejm-fondaparinux-effective-in-superficial-vein-thrombosis/2010-09-23T14:04:34+00:00monthlyhttp://cardiobrief.org/2010/09/22/partner-fundamental-breakthrough-for-transcatheter-aortic-valve-implantation/2010-09-22T23:57:23+00:00monthlyhttp://cardiobrief.org/2010/09/20/fda-panel-unanimously-recommends-approval-for-dabigatran/2010-09-22T10:45:11+00:00monthlyhttp://cardiobrief.org/2010/09/19/guest-post-a-rich-oasis-for-your-journal-club/2010-09-20T16:47:03+00:00monthlyhttp://cardiobrief.org/2010/09/20/soap-opera-star-helps-bi-prepare-the-market-for-pradaxa-dabigatran/2010-09-19T21:33:29+00:00monthlyhttp://cardiobrief.org/2010/09/18/red-light-or-green-light-for-aaa-screening/2010-09-18T20:37:46+00:00monthlyhttp://cardiobrief.org/2010/09/17/fda-announces-safety-review-of-pioglitazone-actos-over-cancer-risk/2010-09-17T18:39:25+00:00monthlyhttp://cardiobrief.org/2010/09/16/fda-panel-votes-9-5-against-approval-of-lorcaserin/2010-09-16T20:02:21+00:00monthlyhttp://cardiobrief.org/2010/09/16/approval-likely-for-dabigatran-as-fda-posts-positive-briefing-documents-for-advisory-panel/2010-09-16T14:16:06+00:00monthlyhttp://cardiobrief.org/2010/09/15/fda-extends-review-of-ticagrelor-brilinta-until-december/2010-09-16T01:27:00+00:00monthlyhttp://cardiobrief.org/2010/09/15/fda-advisory-panel-refuses-to-put-meridia-out-of-its-misery/2010-09-15T22:23:11+00:00monthlyhttp://cardiobrief.org/2010/09/15/treat-analysis-target-dosing-is-tricky/2010-09-15T18:53:15+00:00monthlyhttp://cardiobrief.org/2010/09/15/blue-light-special-aaa-screening-at-kmart-in-the-disease-mongering-aisle/2011-02-17T23:34:35+00:00monthlyhttp://cardiobrief.org/2010/09/14/fda-posts-briefing-documents-for-diet-drug-lorcaserin-investors-get-nervous/2010-09-14T13:53:31+00:00monthlyhttp://cardiobrief.org/2010/09/13/fda-posts-briefing-material-for-meridia-death-panel/2010-09-13T15:26:30+00:00monthlyhttp://cardiobrief.org/2010/09/13/2-fda-rebels-criticize-inclusion-of-avandia-defenders-on-july-advisory-panel/2010-09-13T13:18:53+00:00monthlyhttp://cardiobrief.org/2010/09/12/syntax-at-3-years-cabg-still-winning-but-pci-acceptable-in-low-risk-patients/2010-09-12T02:06:43+00:00monthlyhttp://cardiobrief.org/2010/09/10/roche-halts-use-of-taspolgutide-in-clinical-trials/2010-09-10T23:41:37+00:00monthlyhttp://cardiobrief.org/2010/09/09/lancet-meta-analysis-finds-high-risk-for-carotid-stenting-in-older-patients/2010-09-10T04:17:56+00:00monthlyhttp://cardiobrief.org/2010/09/09/medical-nonprofits-starting-to-disclose-revenue-from-industry/2010-09-09T20:34:06+00:00monthlyhttp://cardiobrief.org/2010/09/09/protective-effect-of-education-only-occurs-in-high-income-countries/2010-09-09T21:23:40+00:00monthlyhttp://cardiobrief.org/2010/09/07/patients-still-overestimate-benefits-of-elective-pci/2010-09-08T02:37:59+00:00monthlyhttp://cardiobrief.org/2010/09/07/bmj-papers-increase-pressure-on-avandia/2010-09-07T15:30:24+00:00monthlyhttp://cardiobrief.org/2010/08/27/the-debate-over-cme-and-industry-influence-continues/2010-09-07T15:38:27+00:00monthlyhttp://cardiobrief.org/2010/09/03/the-rise-of-the-esc-is-the-esc-anti-american-or-pro-industry/2010-09-05T21:07:47+00:00monthlyhttp://cardiobrief.org/2010/09/01/nejm-editors-call-for-removal-of-sibutramine-from-the-us-market/2011-05-05T02:12:37+00:00monthlyhttp://cardiobrief.org/2010/09/01/study-examines-long-term-effect-of-intensive-bp-control-in-blacks/2010-09-01T23:28:10+00:00monthlyhttp://cardiobrief.org/2010/09/01/double-dose-clopidogrel-gains-support-in-current-oasis-7/2010-09-01T23:24:37+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-apixaban-beats-aspirin-for-stroke-prevention-in-af/2010-08-31T20:14:46+00:00monthlyhttp://cardiobrief.org/2010/08/30/circulation-african-americans-at-higher-risk-for-stent-thrombosis/2010-08-31T17:48:41+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-positive-results-for-rivaroxaban-in-einstein-dvt/2010-08-31T08:17:25+00:00monthlyhttp://cardiobrief.org/2010/08/30/dronedarone-and-ticagrelor-speed-into-esc-guidelines/2010-08-30T13:02:29+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-superiority-of-dabigatran-more-evident-in-places-where-inr-is-not-well-controlled/2010-08-29T20:48:59+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-downshifting-heart-rate-in-hf-found-beneficial/2010-09-08T13:19:28+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-alpha-omega-trial-tests-n-3-fatty-acids-in-cv-disease/2010-08-29T20:46:02+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-genetic-substudies-of-large-trials-question-value-of-clopidogrel-genotyping/2010-08-29T20:42:37+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-hot-line-trial-turns-out-to-be-ice-cold/2010-08-29T17:13:52+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-responds-to-controversy-over-previous-publication-of-a-hot-line-trial/2010-08-29T17:12:12+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-no-benefits-for-low-dose-heparin-over-standard-heparin-in-futura-oasis-8/2010-08-29T01:14:14+00:00monthlyhttp://cardiobrief.org/2010/08/30/esc-4-year-findings-from-the-reach-registry/2010-08-29T01:11:05+00:00monthlyhttp://cardiobrief.org/2010/08/28/fda-approves-combination-of-aliskiren-and-amlodipine-for-treatment-of-hypertension/2010-08-29T00:58:38+00:00monthlyhttp://cardiobrief.org/2010/08/26/fda-sets-september-20-date-for-dabigatran-pradaxa-advisory-panel/2010-08-26T17:14:50+00:00monthlyhttp://cardiobrief.org/2010/08/26/i-guess-the-esc-is-really-happening/2010-08-26T16:30:13+00:00monthlyhttp://cardiobrief.org/2010/08/23/aha-late-breakers-ascend-hf-rocket-af-gravitas-gene-therapy-basket-prove-anacetrapib/2010-08-23T23:56:59+00:00monthlyhttp://cardiobrief.org/2010/08/23/cardiobrief-aha-science-advisory-calls-for-more-research-on-cvd-in-asian-americans/2010-08-23T20:57:33+00:00monthlyhttp://cardiobrief.org/2009/04/13/statins-may-have-caused-the-financial-breakdown-according-to-completely-unreliable-experts/2010-08-22T17:55:50+00:00monthlyhttp://cardiobrief.org/2010/08/20/gsk-letter-to-tide-investigators-provokes-avandia-critics/2010-08-20T14:16:08+00:00monthlyhttp://cardiobrief.org/2010/08/17/saving-time-and-setting-the-clock-back-in-ste/2010-08-18T01:30:08+00:00monthlyhttp://cardiobrief.org/2010/08/17/debating-medical-promotion-and-education/2010-08-17T15:24:00+00:00monthlyhttp://cardiobrief.org/2010/08/16/cardiobriefs-red-meat-antagonistic-people-and-chocolate/2010-08-16T22:18:31+00:00monthlyhttp://cardiobrief.org/2010/08/12/crescendo-one-last-aria-for-rimonabant/2010-08-12T23:27:08+00:00monthlyhttp://cardiobrief.org/2010/08/12/ajc-editorial-seriously-proposes-that-statins-be-offered-freely-at-fast-food-restaurants/2010-08-13T07:52:27+00:00monthlyhttp://cardiobrief.org/2010/08/11/shape-shifting-transforming-guidelines-into-a-business-venture/2010-08-11T16:04:24+00:00monthlyhttp://cardiobrief.org/2010/08/10/dallas-valve-meeting-withdraws-previous-statements-about-its-relationship-with%c2%a0theheart-org/2010-08-10T03:26:12+00:00monthlyhttp://cardiobrief.org/2010/08/09/shape-getting-ready-to-update-its-controversial-guidelines/2010-08-10T21:41:32+00:00monthlyhttp://cardiobrief.org/2010/08/06/fda-advisory-panel-will-review-meridia-sibutramine-on-september-15/2010-08-06T18:57:54+00:00monthlyhttp://cardiobrief.org/2010/08/04/at-the-dallas-valve-meeting-even-the-faculty-is-for-sale/2010-08-06T17:55:02+00:00monthlyhttp://cardiobrief.org/2010/08/03/medicines-company-wins-key-ruling-in-effort-to-extend-patent-on-bivalirudin/2010-08-03T21:35:39+00:00monthlyhttp://cardiobrief.org/2010/08/02/calcium-and-the-law-of-unintended-consequences/2010-08-02T17:33:22+00:00monthlyhttp://cardiobrief.org/2010/08/01/donald-shiley-valve-inventor-dead-at-90/2010-08-04T13:56:19+00:00monthlyhttp://cardiobrief.org/2010/07/30/a-missing-piece-of-the-multaq-puzzle-finally-appears-dionysos-published-to-little-fanfare/2010-07-30T21:07:21+00:00monthlyhttp://cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-afternoon-session/2010-07-28T21:13:27+00:00monthlyhttp://cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-morning-session/2010-07-28T16:50:23+00:00monthlyhttp://cardiobrief.org/2010/07/27/mixed-reviews-for-brilinta-prior-to-wednesdays-fda-panel/2010-07-27T15:42:03+00:00monthlyhttp://cardiobrief.org/2010/07/27/terry-ferguson-moves-to-astrazeneca/2010-07-27T14:30:10+00:00monthlyhttp://cardiobrief.org/2010/07/26/fda-finally-posts-briefing-documents-for-brilinta-ticagrelor-advisory-panel/2010-07-26T21:40:05+00:00monthlyhttp://cardiobrief.org/2010/07/26/dc-storm-causes-delay-in-release-of-brilinta-ticagrelor-briefing-materials/2010-07-28T15:36:49+00:00monthlyhttp://cardiobrief.org/2010/07/25/is-it-safe/2010-07-25T20:29:18+00:00monthlyhttp://cardiobrief.org/2010/07/23/fda-refers-avandia-panelist-conflict-of-interest-case-to-hhs-inspector-general/2010-07-24T00:52:13+00:00monthlyhttp://cardiobrief.org/2010/07/23/fda-approves-first-generic-low-molecular-weight-heparin/2010-07-23T23:39:44+00:00monthlyhttp://cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-end/2010-07-21T23:29:56+00:00monthlyhttp://cardiobrief.org/2010/07/21/jupiter-hdl-doesnt-predict-residual-risk-in-statin-treated-patients-with-low-ldl-levels/2010-07-21T18:56:26+00:00monthlyhttp://cardiobrief.org/2010/07/21/fda-puts-tide-on-partial-clinical-hold/2010-07-21T16:54:25+00:00monthlyhttp://cardiobrief.org/2010/05/14/guest-post-shocking-revelations-at-the-hrs/2010-07-21T16:15:45+00:00monthlyhttp://cardiobrief.org/2010/05/24/guest-post-do-hundreds-of-left-atrial-burns-reduce-dementia-risk/2010-07-21T16:15:31+00:00monthlyhttp://cardiobrief.org/2010/07/21/guest-post-prophylactic-icds-may-not-benefit-women/2010-07-21T16:15:18+00:00monthlyhttp://cardiobrief.org/2010/07/20/2-avandia-panel-members-found-to-have-received-money-from-gsk-and-takeda/2010-07-20T21:49:24+00:00monthlyhttp://cardiobrief.org/2010/07/20/avandia-panel-member-received-speaking-fees-from-gsk/2010-07-20T20:57:22+00:00monthlyhttp://cardiobrief.org/2010/07/16/avandia-aftermath-who-are-the-winners-and-losers/2010-07-16T16:26:25+00:00monthlyhttp://cardiobrief.org/2010/07/15/cleveland-clinic-retains-top-position-on-usnwr-list-of-top-heart-hospitalis/2010-07-16T03:38:00+00:00monthlyhttp://cardiobrief.org/2010/07/15/fda-announces-safety-review-of-arbs-and-cancer/2010-07-15T19:31:41+00:00monthlyhttp://cardiobrief.org/2010/07/14/dick-cheney-receives-an-lvad/2010-08-16T01:54:53+00:00monthlyhttp://cardiobrief.org/2010/07/14/gsk-issues-statement-in-response-to-fda-avandia-panel/2010-07-14T21:15:01+00:00monthlyhttp://cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-morning/2010-07-14T16:03:32+00:00monthlyhttp://cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging/2010-07-14T13:46:41+00:00monthlyhttp://cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging-the-afternoon/2010-07-14T02:13:10+00:00monthlyhttp://cardiobrief.org/2010/07/13/ny-times-gsk-concealed-negative-avandia-study/2010-07-13T17:18:08+00:00monthlyhttp://cardiobrief.org/2010/07/12/effient-and-verifynow-a-match-made-in-heaven/2010-07-23T07:58:04+00:00monthlyhttp://cardiobrief.org/2010/07/12/handicapping-the-avandia-fda-panel/2010-07-12T19:47:05+00:00monthlyhttp://cardiobrief.org/2010/07/09/fda-posts-avandia-briefing-documents-ahead-of-next-weeks-advisory-panel-meeting/2010-07-11T19:23:50+00:00monthlyhttp://cardiobrief.org/2010/07/09/pioglitazone-beats-rosiglitazone-in-fda-review-of-controlled-epidemiologic-studies/2010-07-09T18:53:26+00:00monthlyhttp://cardiobrief.org/2010/07/09/5-different-ways-of-spinning-record/2010-07-09T16:56:01+00:00monthlyhttp://cardiobrief.org/2010/07/08/authors-of-jupiter-attack-committed-self-plagiarism/2010-07-23T23:47:36+00:00monthlyhttp://cardiobrief.org/2010/07/07/nejm-editors-were-not-fully-aware-of-gsk-and-merck-manipulation-of-avandia-and-vytorin-dsmbs/2010-07-07T22:32:24+00:00monthlyhttp://cardiobrief.org/2010/07/02/why-was-an-abbott-marketing-study-published-in-the-american-journal-of-cardiology-2/2010-07-07T16:06:39+00:00monthlyhttp://cardiobrief.org/2010/07/06/study-finds-no-benefit-for-tight-bp-control-in-diabetics-with-cad/2010-07-07T15:43:18+00:00monthlyhttp://cardiobrief.org/2010/07/01/trial-raises-concerns-over-cv-safety-of-testosterone-gel/2010-07-01T19:07:21+00:00monthlyhttp://cardiobrief.org/2010/06/30/prasugrel-critics-once-again-raise-cancer-concerns/2010-06-30T19:30:46+00:00monthlyhttp://cardiobrief.org/2010/06/29/accord-analyses-find-a-few-faint-glimmers-of-hope/2010-06-30T00:05:53+00:00monthlyhttp://cardiobrief.org/2010/06/29/authors-of-jupiter-attack-are-members-of-obscure-anti-cholesterol-group/2010-08-15T13:18:53+00:00monthlyhttp://cardiobrief.org/2010/06/28/meta-analysis-questions-value-of-statins-for-primary-prevention-jupiter-comes-under-attack/2010-07-02T14:15:26+00:00monthlyhttp://cardiobrief.org/2010/06/28/acc-and-aha-respond-to-boxed-warning-on-clopidogrel/2010-06-28T18:20:16+00:00monthlyhttp://cardiobrief.org/2010/06/28/tightening-the-noose-yet-again-on-avandia/2010-06-28T14:05:07+00:00monthlyhttp://cardiobrief.org/2010/06/26/once-weekly-exenatide-performs-well-in-duration-2/2010-06-25T22:01:54+00:00monthlyhttp://cardiobrief.org/2010/06/24/ada-kicks-off-with-lancet-papers-on-cv-deaths-in-diabetes-once-weekly-exenatide-and-dapagliflozin/2010-06-25T13:48:32+00:00monthlyhttp://cardiobrief.org/2010/06/25/chmp-recommends-european-approval-for-vernakalant-for-recent-onset-af/2010-06-25T13:26:09+00:00monthlyhttp://cardiobrief.org/2010/06/24/milwaukee-hospital-misreads-30-of-echocardiograms/2010-06-24T14:35:44+00:00monthlyhttp://cardiobrief.org/2010/06/23/accme-reverses-rule-that-would-have-prevented-industry-employees-from-speaking-at-scientific-sessions/2010-06-24T00:00:31+00:00monthlyhttp://cardiobrief.org/2010/06/23/cardiobriefs-eas-to-recommend-niacin-and-lpa-screening-lowering-homocysteine-fails-again/2010-06-24T03:20:26+00:00monthlyhttp://cardiobrief.org/2010/06/22/cardiobriefs-aggrenox-study-fails-livalo-launched-ny-times-spotlights-icds-with-benefits/2011-07-31T18:55:42+00:00monthlyhttp://cardiobrief.org/2010/06/21/cardiologist-accused-of-prescribing-unnecessary-icds-because-his-son-was-a-st-jude-salesman/2010-06-21T23:57:49+00:00monthlyhttp://cardiobrief.org/2010/06/19/what-do-outside-cardiologists-think-about-the-unread-echocardiograms-at-harlem-hospital/2010-06-21T00:53:47+00:00monthlyhttp://cardiobrief.org/2010/06/18/german-committee-recommends-against-reimbursement-for-avandia-and-actos/2010-06-18T19:47:01+00:00monthlyhttp://cardiobrief.org/2010/06/18/interstroke-accounting-for-stroke/2010-06-18T15:27:00+00:00monthlyhttp://cardiobrief.org/2010/06/18/new-delays-for-taspoglutide-renewed-cancer-concerns-for-insulin-glargine/2010-06-18T13:57:29+00:00monthlyhttp://cardiobrief.org/2010/06/17/trial-of-pfo-closure-fails-to-meet-primary-endpoint/2010-06-17T20:00:02+00:00monthlyhttp://cardiobrief.org/2010/06/16/industry-employees-no-longer-allowed-to-speak-at-aha-scientific-sessions/2010-06-16T22:13:51+00:00monthlyhttp://cardiobrief.org/2010/06/16/esc-posts-hot-line-trials-for-2010-congress-in-stockholm/2010-06-16T21:15:54+00:00monthlyhttp://cardiobrief.org/2010/06/16/cardiobriefs-new-generation-stent-tested-bms-versus-des-for-stemi/2010-06-16T20:05:20+00:00monthlyhttp://cardiobrief.org/2010/06/15/hdl-and-cancer-study-finds-strong-inverse-relationship/2010-06-15T15:41:34+00:00monthlyhttp://cardiobrief.org/2010/06/13/meta-analysis-finds-increased-risk-of-cancer-associated-with-arbs/2010-06-13T19:15:48+00:00monthlyhttp://cardiobrief.org/2010/06/11/fda-reviewing-safety-of-olmesartan-benicar/2010-07-11T23:20:41+00:00monthlyhttp://cardiobrief.org/2010/06/11/chicago-cardiologist-morton-arnsdorf-dies-in-car-crash/2010-06-11T13:32:32+00:00monthlyhttp://cardiobrief.org/2010/06/10/trial-comparing-apixaban-to-aspirin-in-af-stopped-for-efficacy/2010-06-10T22:56:48+00:00monthlyhttp://cardiobrief.org/2010/06/10/new-unpublished-study-may-help-tighten-the-noose-around-avandias-neck/2010-06-13T21:33:35+00:00monthlyhttp://cardiobrief.org/2010/06/09/cardiobriefs-mis-decline-over-past-decade-smoke-free-legislation-reduces-mi-admissions-in-england/2010-06-10T03:44:09+00:00monthlyhttp://cardiobrief.org/2010/06/08/atrial-fibrillation-a-big-messy-problem/2010-06-09T08:39:03+00:00monthlyhttp://cardiobrief.org/2010/06/04/fda-schedules-avandia-advisory-panel-for-july-13-14/2010-06-07T22:49:02+00:00monthlyhttp://cardiobrief.org/2010/06/06/investigators-in-maryland-expand-investigation-of-unnecessary-stenting/2010-06-06T21:02:42+00:00monthlyhttp://cardiobrief.org/2010/05/17/good-morning-american-segment-lands-some-hard-punches-on-the-aha/2011-05-16T20:10:20+00:00monthlyhttp://cardiobrief.org/2010/06/03/up-the-avandia-creek-without-a-paddle-canoe/2010-06-03T14:56:25+00:00monthlyhttp://cardiobrief.org/2010/06/02/fda-schedules-july-advisory-panel-for-brilinta-ticagrelor/2010-06-03T13:07:22+00:00monthlyhttp://cardiobrief.org/2010/06/02/listening-to-industry-whats-the-roi-of-medical-education/2010-08-27T15:45:11+00:00monthlyhttp://cardiobrief.org/2010/06/01/handicapping-the-july-fda-panel-on-avandia/2010-06-01T19:56:35+00:00monthlyhttp://cardiobrief.org/2010/05/31/can-we-trust-athena/2010-05-31T19:25:37+00:00monthlyhttp://cardiobrief.org/2010/05/29/at-least-200-patients-with-unread-echocardiograms-have-died/2010-05-29T23:36:26+00:00monthlyhttp://cardiobrief.org/2010/05/28/think-about-it-4000-echocardiograms-were-not-only-unread-but-unmissed/2010-05-29T13:40:54+00:00monthlyhttp://cardiobrief.org/2010/05/28/over-3-years-4000-echocardiograms-went-unread-at-nycs-harlem-hospital/2010-05-28T17:43:25+00:00monthlyhttp://cardiobrief.org/2010/05/28/even-more-people-may-have-received-unnecessary-stents-at-st-josephs/2010-05-28T17:10:29+00:00monthlyhttp://cardiobrief.org/2010/05/27/eplerenone-trial-stopped-early-after-reaching-its-primary-endpoint/2010-05-27T13:07:10+00:00monthlyhttp://cardiobrief.org/2009/03/11/statins-reduce-energy-and-interest-in-activty-new-study-suggests/2010-05-26T21:32:53+00:00monthlyhttp://cardiobrief.org/2010/05/26/guest-post-steve-nissen-and-jack-lewin-debate-interactions-with-industry/2010-05-26T18:11:57+00:00monthlyhttp://cardiobrief.org/2010/05/24/francis-collins-proposes-new-conflict-of-interest-rules-for-nih-funded-researchers-and-institutions/2010-05-24T14:41:22+00:00monthlyhttp://cardiobrief.org/2010/05/20/is-time-starting-to-run-out-for-tide-and-avandia/2010-05-20T04:39:33+00:00monthlyhttp://cardiobrief.org/2010/05/18/why-we-shouldnt-kill-all-the-lawyers-just-yet/2010-05-19T01:06:38+00:00monthlyhttp://cardiobrief.org/2010/05/07/vioxx-avandia-vytorin-absolute-risk-versus-relative-risk/2010-05-17T13:29:57+00:00monthlyhttp://cardiobrief.org/2010/05/14/guest-post-badness-in-baltimore-can-peer-review-catch-rogue-doctors/2010-05-14T21:25:26+00:00monthlyhttp://cardiobrief.org/2010/05/12/topol-vs-gurbel-experts-split-on-routine-genotyping-for-dapt/2010-05-13T14:06:31+00:00monthlyhttp://cardiobrief.org/2010/05/12/gust-bardy-answers-questions-about-the-entirely-subcutaneous-icd/2010-05-13T05:48:46+00:00monthlyhttp://cardiobrief.org/2010/05/10/lancet-meta-analysis-finds-some-benefits-for-fibrates/2010-05-10T20:38:26+00:00monthlyhttp://cardiobrief.org/2010/05/07/medtronic-tells-physicians-about-rare-software-issue-with-its-icds/2010-05-19T19:56:54+00:00monthlyhttp://cardiobrief.org/2010/05/05/hong-kong-authorities-issue-warning-about-medtronic-icds/2010-05-05T23:34:35+00:00monthlyhttp://cardiobrief.org/2010/05/05/stentapalooza-wednesday-spirit-iv-and-main-compare/2010-05-05T20:31:22+00:00monthlyhttp://cardiobrief.org/2010/05/04/the-wealth-gap-are-cardiologists-high-salaries-standing-in-the-way-of-primary-care/2010-05-04T20:38:55+00:00monthlyhttp://cardiobrief.org/2010/04/30/ehj-editors-rebuffed-gsk-efforts-to-suppress-nissen-editorial-on-rosiglitazone/2010-05-03T13:06:56+00:00monthlyhttp://cardiobrief.org/2010/04/30/the-survey-says-uphill-battle-for-effient-plavix-remains-strong-anticipation-grows-for-brillinta/2010-04-30T18:08:10+00:00monthlyhttp://cardiobrief.org/2010/04/29/tmi-personal-genome-used-in-clinical-assessment/2010-04-29T20:49:54+00:00monthlyhttp://cardiobrief.org/2010/04/29/roche-announces-more-positive-results-for-taspoglutide/2010-04-29T13:21:34+00:00monthlyhttp://cardiobrief.org/2010/04/28/vitamin-b-and-steroids-monuments-to-human-folly/2010-04-30T23:34:22+00:00monthlyhttp://cardiobrief.org/2010/04/27/us-judge-rejects-guidant-296-million-plea-agreement/2010-04-28T00:16:44+00:00monthlyhttp://cardiobrief.org/2010/04/27/calcium-screening-another-positive-study-another-critical-editorial/2010-04-27T19:27:35+00:00monthlyhttp://cardiobrief.org/2010/04/26/ppis-and-clopidogrel-new-study-finds-evidence-that-pantoprazole-may-also-be-a-problem/2010-04-26T20:01:35+00:00monthlyhttp://cardiobrief.org/2010/04/22/guest-post-medical-societies-new-ethics-code-secret-qa-document-revealed/2010-04-22T19:38:51+00:00monthlyhttp://cardiobrief.org/2010/04/21/guest-post-the-long-afterlife-of-joshua-oukrop/2010-04-21T18:48:22+00:00monthlyhttp://cardiobrief.org/2010/04/20/iom-report-heralds-new-fda-initiative-to-gradually-cut-salt-in-processed-foods/2010-04-20T18:51:49+00:00monthlyhttp://cardiobrief.org/2010/04/20/small-steps-lead-to-big-reduction-in-risk-for-overweight-mayo-clinic-cardiologist/2010-04-20T14:10:43+00:00monthlyhttp://cardiobrief.org/2010/04/18/residual-risk-reduction-initiative-promotion-or-education/2010-04-19T01:16:03+00:00monthlyhttp://cardiobrief.org/2010/04/15/boston-scientific-resumes-sales-of-cognis-and-teligen-icds/2010-04-16T00:34:04+00:00monthlyhttp://cardiobrief.org/2010/04/15/even-more-questions-about-multaq-and-prystowsky-alas/2010-04-16T21:19:16+00:00monthlyhttp://cardiobrief.org/2010/04/14/final-results-of-arbiter-6-halts-confirm-cimt-benefit-with-niacin-and-no-benefit-with-ezetimibe/2010-04-14T16:50:01+00:00monthlyhttp://cardiobrief.org/2010/04/13/promising-early-results-for-valve-in-valve-approach-to-failing-bioprosthetic-valves/2010-04-13T16:24:01+00:00monthlyhttp://cardiobrief.org/2010/04/12/guest-post-running-on-empty/2010-04-12T19:19:58+00:00monthlyhttp://cardiobrief.org/2010/04/11/nejm-trials-find-few-long-term-benefits-for-endovascular-aaa-repair/2010-04-10T18:44:17+00:00monthlyhttp://cardiobrief.org/2010/04/08/more-pieces-of-the-multaq-puzzle/2010-04-09T11:13:15+00:00monthlyhttp://cardiobrief.org/2010/04/07/survival-after-cabg-isn%e2%80%99t-about-skin-color-or-gender-it%e2%80%99s-about-being-poor/2010-04-07T22:25:01+00:00monthlyhttp://cardiobrief.org/2010/04/06/guest-post-the-ipad-goes-live-at-bidmc-2/2010-04-07T12:46:11+00:00monthlyhttp://cardiobrief.org/2010/04/06/experts-disagree-on-when-to-use-dronedarone-multaq/2010-04-06T19:40:40+00:00monthlyhttp://cardiobrief.org/2010/04/05/waiting-for-improve-it/2010-04-05T21:04:12+00:00monthlyhttp://cardiobrief.org/2010/03/31/prystowsky-lectures-resurfaces-this-time-with-coi-disclosures/2010-03-31T21:38:58+00:00monthlyhttp://cardiobrief.org/2010/03/26/more-multaq-prystowsky-whack-a-mole-acc-responds-sanofi-overtures-to-eps/2010-03-31T20:22:35+00:00monthlyhttp://cardiobrief.org/2010/03/25/pieces-of-a-puzzle-multaq-sanofi-acc-hrs-prystowsky-af-guidelines/2010-03-31T18:44:21+00:00monthlyhttp://cardiobrief.org/2010/03/31/new-york-times-broader-indication-for-rosuvastatin-once-again-raises-risk-vs-benefit-in-healthy-population/2010-04-01T14:32:42+00:00monthlyhttp://cardiobrief.org/2010/03/30/sec-and-doj-looking-into-boston-scientific-icd-recall/2010-04-04T16:59:08+00:00monthlyhttp://cardiobrief.org/2010/03/30/uks-nice-plays-a-bit-nicer-with-multaq-dronedarone/2010-03-30T17:29:17+00:00monthlyhttp://cardiobrief.org/2010/03/30/fda-delays-approval-of-certriad-rosuvastatinfenofibric-acid-combo/2010-03-30T16:34:53+00:00monthlyhttp://cardiobrief.org/2010/03/29/archimedes-the-computer-model-not-the-greek-supports-screening-for-diabetes/2010-03-29T21:31:47+00:00monthlyhttp://cardiobrief.org/2010/03/27/ny-times-most-nitroglycerin-in-the-us-is-in-regulatory-limbo/2010-03-27T23:22:56+00:00monthlyhttp://cardiobrief.org/2010/03/26/wtf-now-you-can-diagnose-your-own-heart-attack-right-at-home/2010-03-26T20:50:02+00:00monthlyhttp://cardiobrief.org/2010/03/23/avandia-again-nissen-and-jama-editors-spin-record-round-and-round/2010-03-23T22:03:37+00:00monthlyhttp://cardiobrief.org/2010/03/22/why-is-there-a-red-dress-on-diet-coke-cans/2011-07-08T02:13:56+00:00monthlyhttp://cardiobrief.org/2010/03/22/james-black-nobel-laureate-who-invented-beta-blockers-dead-at-85/2010-03-22T19:32:48+00:00monthlyhttp://cardiobrief.org/2010/03/20/fda-panel-recommends-approval-of-medtronics-mri-safe-pacemaker/2010-03-20T18:20:01+00:00monthlyhttp://cardiobrief.org/2010/03/19/fda-warns-about-increased-risk-of-myopathy-with-80-mg-simvastatin/2010-03-19T15:38:34+00:00monthlyhttp://cardiobrief.org/2010/03/18/fda-panel-supports-expanded-indication-for-crt-ds/2010-03-19T02:45:17+00:00monthlyhttp://cardiobrief.org/2010/03/18/fda-watchman-device-will-need-to-wait-a-bit-longer/2011-05-04T15:32:27+00:00monthlyhttp://cardiobrief.org/2010/03/18/more-details-emerge-about-boston-scientifics-suspension-of-icd-sales/2010-03-18T19:35:29+00:00monthlyhttp://cardiobrief.org/2010/03/18/guest-post-freezing-in-af-ablation-not-so-fast-you-all/2010-03-18T18:08:49+00:00monthlyhttp://cardiobrief.org/2010/03/17/fda-panel-set-to-review-expanded-indication-for-crt-d-and-first-mri-safe-pacing-system-new-mri/2010-03-17T17:45:19+00:00monthlyhttp://cardiobrief.org/2010/03/17/ahaacc-release-thoracic-aortic-disease-guidelines/2012-01-12T10:22:12+00:00monthlyhttp://cardiobrief.org/2010/03/16/cabg-in-platos-cave-is-the-reduction-in-mortality-real-or-an-illusion/2010-03-16T19:50:44+00:00monthlyhttp://cardiobrief.org/2010/03/15/us-attorneys-office-investigating-medtronic-over-ties-to-lahey-clinic-cardiologists/2010-03-15T17:38:50+00:00monthlyhttp://cardiobrief.org/2010/03/15/fda-says-it-will-review-the-accord-data/2010-03-15T17:00:01+00:00monthlyhttp://cardiobrief.org/2010/03/13/the-countdown-begins/2010-03-15T15:50:02+00:00monthlyhttp://cardiobrief.org/2010/03/15/sort-out-iii-chucks-out-zotarolimus-eluting-stents/2010-03-15T15:55:57+00:00monthlyhttp://cardiobrief.org/2010/03/15/boston-scientific-reportedly-suspends-icd-sales-due-to-administrative-errors/2010-03-15T14:22:43+00:00monthlyhttp://cardiobrief.org/2010/03/14/navigator-provides-little-guidance-in-diabetes/2010-03-14T19:19:38+00:00monthlyhttp://cardiobrief.org/2010/03/14/everest-ii-catheter-based-mitral-repair-system-reaches-new-peak/2010-03-14T19:13:39+00:00monthlyhttp://cardiobrief.org/2010/03/15/optimal-duration-of-dual-antiplatelet-therapy-still-unresolved/2010-03-14T17:30:22+00:00monthlyhttp://cardiobrief.org/2010/03/15/race-ii-dont-rush-to-slow-down/2010-03-14T15:45:58+00:00monthlyhttp://cardiobrief.org/2010/03/14/accord-fails-to-find-benefits-for-fenofibrate-or-lower-blood-pressure-target/2010-03-14T15:36:11+00:00monthlyhttp://cardiobrief.org/2010/03/13/acc-duke-study-links-stock-market-to-cardiac-events/2010-03-13T16:26:03+00:00monthlyhttp://cardiobrief.org/2010/03/12/plavix-label-gets-black-box-warning-about-poor-metabolizers/2010-03-12T23:33:20+00:00monthlyhttp://cardiobrief.org/2010/03/13/mipomersen-cuts-ldl-by-25-in-homozygous-fh-but-safety-concerns-remain/2010-03-12T00:31:55+00:00monthlyhttp://cardiobrief.org/2010/03/11/landslide-of-lancet-papers-suggest-importance-of-blood-pressure-variability/2010-03-12T00:10:24+00:00monthlyhttp://cardiobrief.org/2010/03/10/nejm-study-finds-low-diagnostic-yield-for-coronary-angiography/2010-03-10T22:13:56+00:00monthlyhttp://cardiobrief.org/2010/03/08/redberg-critical-of-obamas-coronary-calcium-scan/2010-03-09T00:34:07+00:00monthlyhttp://cardiobrief.org/2010/02/08/study-finds-significant-lesions-in-one-fifth-of-patients-with-zero-calcium-scores/2010-03-09T00:30:01+00:00monthlyhttp://cardiobrief.org/2010/03/08/calcium-scans-do-they-now-come-with-a-warranty/2010-09-24T20:01:05+00:00monthlyhttp://cardiobrief.org/2010/03/04/advance-2-apixaban-study-published-in-lancet/2010-03-04T18:48:27+00:00monthlyhttp://cardiobrief.org/2010/03/04/guest-post-sanjay-kaul-answers-questions-about-rosiglitazone/2010-03-04T13:47:04+00:00monthlyhttp://cardiobrief.org/2010/03/02/icd-implantation-may-cause-cognitive-problems-small-study-suggests/2010-03-26T03:30:40+00:00monthlyhttp://cardiobrief.org/2010/03/01/screening-young-athletes-to-ecg-or-not-to-ecg/2010-03-01T21:32:15+00:00monthlyhttp://cardiobrief.org/2009/02/17/new-data-on-sudden-death-in-young-athletes-published/2010-03-01T19:44:52+00:00monthlyhttp://cardiobrief.org/2010/02/26/crest-finds-carotid-stenting-broadly-equivalent-to-endarterectomy/2010-02-26T16:42:17+00:00monthlyhttp://cardiobrief.org/2010/02/25/carotid-endarterectomy-beats-stenting-in-first-results-from-icss/2010-02-25T23:50:12+00:00monthlyhttp://cardiobrief.org/2010/02/24/avandia-a-plaque-on-both-your-houses/2010-05-01T02:01:15+00:00monthlyhttp://cardiobrief.org/2010/02/23/jama-study-questions-value-of-platelet-function-tests-in-pci-patients/2010-02-23T23:27:08+00:00monthlyhttp://cardiobrief.org/2010/02/22/more-avandia-action-nissen-recorded-gsk-execs-fda-announces-safety-review/2010-02-23T02:47:10+00:00monthlyhttp://cardiobrief.org/2010/02/20/senate-releases-avandia-report-gsk-responds-to-attacks/2010-02-20T20:32:14+00:00monthlyhttp://cardiobrief.org/2010/02/20/ny-times-fda-and-senate-reports-slam-continued-availability-of-avandia-rosiglitazone/2010-02-20T05:21:32+00:00monthlyhttp://cardiobrief.org/2010/02/22/study-finds-increased-rate-of-stent-thrombosis-in-primary-pci-patients-who-get-distal-protection/2010-02-19T22:59:38+00:00monthlyhttp://cardiobrief.org/2010/02/17/accomplish-amlodopine-may-or-may-not-be-better-than-hydrochlorothiazide-in-combo-with-benazepril-to-slow-progression-of-kidney-disease/2010-02-18T00:13:15+00:00monthlyhttp://cardiobrief.org/2010/02/16/lancet-large-meta-analysis-confirms-small-increase-in-diabetes-with-statins/2010-02-17T22:44:40+00:00monthlyhttp://cardiobrief.org/2010/02/17/arts-ii-at-5-years-what-have-we-learned/2010-02-17T20:43:24+00:00monthlyhttp://cardiobrief.org/2010/02/16/jama-studies-find-little-evidence-to-support-genetic-testing-to-improve-cv-risk-assessment/2010-02-16T21:04:44+00:00monthlyhttp://cardiobrief.org/2010/02/12/boston-scientific-ceo-were-the-reports-of-icd-flaws-tied-to-attempts-to-drive-down-the-stock-price/2010-02-13T21:54:40+00:00monthlyhttp://cardiobrief.org/2010/02/11/roche-announces-more-positive-results-for-taspoglutide-but/2010-02-11T19:55:29+00:00monthlyhttp://cardiobrief.org/2009/12/02/roches-taspoglutide-beats-sitagliptin-in-phase-iii-trial/2010-02-11T19:35:16+00:00monthlyhttp://cardiobrief.org/2010/02/10/boston-scientific-and-william-maisel-clash-over-icd-flaws/2010-02-11T03:53:28+00:00monthlyhttp://cardiobrief.org/2010/02/08/rosuvastatin-crestor-gains-expanded-primary-prevention-indication/2010-06-16T04:11:15+00:00monthlyhttp://cardiobrief.org/2010/02/08/new-concerns-raised-about-boston-scientific-icds/2010-02-08T23:48:28+00:00monthlyhttp://cardiobrief.org/2010/02/06/the-two-sides-of-aspirin-too-much-and-not-enough/2010-02-06T20:17:26+00:00monthlyhttp://cardiobrief.org/2010/02/05/more-adverse-events-seen-in-patients-on-ppis-after-des/2010-02-05T22:11:04+00:00monthlyhttp://cardiobrief.org/2010/02/02/live-af-ablation-broadcast-on-today-show-whats-wrong-with-this-picture/2010-03-12T04:46:50+00:00monthlyhttp://cardiobrief.org/2010/02/02/alderman-in-jama-universal-sodium-reductions-are-a-rash-route/2010-02-03T01:23:15+00:00monthlyhttp://cardiobrief.org/2010/02/01/boston-scientific-pays-1-725-to-jj-to-settle-three-patent-disputes-over-stents/2010-02-01T20:20:23+00:00monthlyhttp://cardiobrief.org/2010/01/29/guest-post-chantix-and-cardiovascular-risk-another-weak-safety-study/2010-02-10T23:33:23+00:00monthlyhttp://cardiobrief.org/2010/01/28/lilly-reports-modest-sales-figures-for-effient-prasugrel/2010-01-28T17:33:26+00:00monthlyhttp://cardiobrief.org/2010/01/28/acc-10-i2-summit-in-atlanta-late-breaking-clinical-trials/2010-01-28T00:34:45+00:00monthlyhttp://cardiobrief.org/2010/01/27/study-identifies-shortcut-to-diagnosing-long-qt-syndrome/2010-01-27T18:33:52+00:00monthlyhttp://cardiobrief.org/2010/01/26/cath-lab-coming-attractions-3d-images-of-the-coronary-arteries/2010-01-27T13:18:28+00:00monthlyhttp://cardiobrief.org/2010/01/26/lancet-researchers-find-goldilocks-effect-in-glucose-control-for-diabetes/2010-01-26T19:48:40+00:00monthlyhttp://cardiobrief.org/2010/01/25/fda-approves-liraglutide-victoza-for-type-2-diabetes/2010-01-26T15:32:14+00:00monthlyhttp://cardiobrief.org/2010/01/26/jama-rf-ablation-superior-to-drugs-in-multicenter-af-trial/2010-01-26T15:25:33+00:00monthlyhttp://cardiobrief.org/2010/01/25/fda-approves-first-percutaneous-heart-valve-medtronics-melody-pulmonary-valve/2010-03-15T21:51:35+00:00monthlyhttp://cardiobrief.org/2010/01/21/generic-clopidogrel-besilate-makes-inroads-into-european-plavix-market/2010-01-22T19:38:19+00:00monthlyhttp://cardiobrief.org/2010/01/22/sandoz-starts-to-prepare-for-generic-enoxaparin-in-the-us/2010-01-22T18:46:01+00:00monthlyhttp://cardiobrief.org/2010/01/20/nejm-study-and-editorial-advocate-widespread-salt-reductions/2010-01-22T17:21:03+00:00monthlyhttp://cardiobrief.org/2010/01/21/european-medicines-agency-recommends-suspension-of-sibutramine/2010-01-21T22:55:49+00:00monthlyhttp://cardiobrief.org/2010/01/21/fda-sibutramine-now-contraindicated-in-people-with-cardiovascular-disease/2010-01-21T17:54:23+00:00monthlyhttp://cardiobrief.org/2010/01/20/nih-puts-baylor-on-a-tight-leash-after-failing-to-disclose-merck-payments-to-ballantyne/2010-01-21T13:44:10+00:00monthlyhttp://cardiobrief.org/2010/01/20/heartmate-ii-lvas-gains-destination-therapy-indication/2010-01-20T18:09:13+00:00monthlyhttp://cardiobrief.org/2009/11/17/aha-58-survival-rate-at-2-years-with-heartmate-ii-continuous-flow-lvad/2010-01-20T18:05:13+00:00monthlyhttp://cardiobrief.org/2010/01/19/study-suggests-fixed-doses-of-statins-may-be-better-than-treating-to-target/2010-01-19T19:37:51+00:00monthlyhttp://cardiobrief.org/2010/01/15/maryland-hospital-tells-hundreds-of-heart-patients-their-stents-may-have-been-unnecessary/2010-01-16T02:10:38+00:00monthlyhttp://cardiobrief.org/2010/01/13/the-introduction-of-ticagrelor-a-more-potent-and-effective-agent-which-is-as-safe-as-its-predecessor-is-a-landmark-event-that-should-redefine-the-care-of-patients-with-acute-coronary-syndromes/2010-01-14T20:28:34+00:00monthlyhttp://cardiobrief.org/2010/01/14/new-research-links-radiation-exposure-to-cv-disease/2010-01-14T20:23:01+00:00monthlyhttp://cardiobrief.org/2010/01/13/judge-rejects-acc-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2010-01-14T04:28:04+00:00monthlyhttp://cardiobrief.org/2010/01/13/syntax-have-drug-eluting-stents-removed-the-death-penalty-associated-with-diabetes-and-multivessel-pci/2010-01-13T20:25:03+00:00monthlyhttp://cardiobrief.org/2010/01/12/cocaine-plays-role-in-3-of-sudden-deaths-in-spain/2010-01-12T22:09:23+00:00monthlyhttp://cardiobrief.org/2010/01/12/increasing-adherence-to-statins-would-save-twice-the-number-of-lives-as-expanding-eligibility/2010-01-12T19:15:42+00:00monthlyhttp://cardiobrief.org/2010/01/11/fdas-cardiorenal-panel-unanimously-rejects-nebivolol-for-hf/2010-01-11T22:43:46+00:00monthlyhttp://cardiobrief.org/2010/01/11/archives-not-all-guidelines-are-created-equal/2010-01-11T19:35:34+00:00monthlyhttp://cardiobrief.org/2010/01/08/reevaluating-esas-too-little-too-late/2010-01-08T22:35:38+00:00monthlyhttp://cardiobrief.org/2010/01/07/compare-investigators-in-the-lancet-paclitaxel-eluting-stents-should-no-longer-be-used-in-everyday-clinical-practice/2010-01-08T16:40:05+00:00monthlyhttp://cardiobrief.org/2010/01/08/completion-of-improve-it-now-delayed-until-june-2013/2010-01-08T15:19:47+00:00monthlyhttp://cardiobrief.org/2010/01/07/note-to-readers-cardiobrief-editor-to-join-forces-with-nejms-cardioexchange/2010-01-07T22:46:47+00:00monthlyhttp://cardiobrief.org/2010/01/07/fda-staff-recommends-against-heart-failure-indication-for-bystolic-nebivolol/2010-01-07T18:29:36+00:00monthlyhttp://cardiobrief.org/2010/01/06/nejm-fda-to-reevaluate-esas-in-treatment-of-anemia/2010-01-06T20:21:25+00:00monthlyhttp://cardiobrief.org/2010/01/04/braunwald-in-all-fairness-what-was-ok-three-years-ago-is-not-ok-now-%e2%80%9d/2010-01-05T13:48:14+00:00monthlyhttp://cardiobrief.org/2009/12/31/leading-israeli-cardiologists-blocking-their-countrys-participation-in-planned-nih-funded-ischemia-trial/2009-12-31T19:33:20+00:00monthlyhttp://cardiobrief.org/2009/12/30/ictus-at-5-years-still-fails-to-find-benefit-for-early-invasive-strategy-in-acs/2009-12-30T20:22:23+00:00monthlyhttp://cardiobrief.org/2009/12/29/second-study-on-approval-of-cv-devices-largely-confirms-fda-deficiencies/2009-12-30T01:38:47+00:00monthlyhttp://cardiobrief.org/2009/12/29/jama-review-finds-lack-of-rigor-in-fda-approval-of-cv-devices/2009-12-29T22:24:59+00:00monthlyhttp://cardiobrief.org/2009/12/29/acc-files-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2009-12-29T20:31:27+00:00monthlyhttp://cardiobrief.org/2009/12/28/ahj-editorial-calls-for-something-equivalent-to-fluoride-in-the-drinking-water-to-fight-scd/2009-12-28T23:59:48+00:00monthlyhttp://cardiobrief.org/2009/12/24/study-finds-sprint-fidelis-lead-fractures-increasing-exponentially/2009-12-24T16:09:58+00:00monthlyhttp://cardiobrief.org/2009/12/21/lancet-huge-metaanalysis-finds-no-causative-role-of-crp/2009-12-23T23:54:46+00:00monthlyhttp://cardiobrief.org/2009/12/23/nejm-1-in-6-persons-have-lpa-variant-associated-with-increased-cad-risk/2009-12-23T16:12:15+00:00monthlyhttp://cardiobrief.org/2009/12/22/medicines-company-buys-apoa-1-milano-from-pfizer/2009-12-23T15:51:53+00:00monthlyhttp://cardiobrief.org/2009/12/22/genes-stem-cells-ticagrelor-and-dabigatran-among-ahas-top-10-for-2009/2009-12-22T18:43:50+00:00monthlyhttp://cardiobrief.org/2009/12/22/fda-says-cancer-risk-of-vytorin-and-zetia-is-unlikely/2009-12-30T23:27:33+00:00monthlyhttp://cardiobrief.org/2009/12/21/niacin-helps-restore-hdl-protective-effects-in-diabetics/2009-12-22T01:49:34+00:00monthlyhttp://cardiobrief.org/2009/12/18/primary-pci-without-surgical-backup-deemed-safe-in-nys-study/2009-12-18T15:21:29+00:00monthlyhttp://cardiobrief.org/2009/12/17/cardiome-says-vernakalant-bests-amiodarone-in-acute-conversion-of-af/2009-12-18T00:04:14+00:00monthlyhttp://cardiobrief.org/2009/12/17/aha-cv-disease-will-cost-500-billion-in-2010/2009-12-17T19:58:39+00:00monthlyhttp://cardiobrief.org/2009/12/17/roche-announces-positive-results-for-2-more-taspoglutide-trials/2010-02-18T19:15:39+00:00monthlyhttp://cardiobrief.org/2009/12/16/tcfa-the-most-relevant-form-of-human-disease-in-the-history-of-mankind/2009-12-16T21:38:40+00:00monthlyhttp://cardiobrief.org/2009/12/10/lancet-bleeding-risk-in-mi-patients-increases-with-dual-and-triple-therapy/2009-12-16T17:33:41+00:00monthlyhttp://cardiobrief.org/2009/12/15/fda-advisory-panel-backs-expanded-indication-for-crestor-rosuvastatin/2009-12-15T23:44:40+00:00monthlyhttp://cardiobrief.org/2009/12/15/review-finds-no-consistent-or-reproducible-treatment-effect-of-serial-calcium-scans/2009-12-30T23:24:40+00:00monthlyhttp://cardiobrief.org/2009/12/14/are-ct-scans-the-wild-west-of-todays-medicine/2009-12-15T17:57:38+00:00monthlyhttp://cardiobrief.org/2009/12/11/fda-sets-stage-for-tuesdays-crestor-rosuvastatin-advisory-panel/2009-12-11T22:30:24+00:00monthlyhttp://cardiobrief.org/2009/12/10/wired-david-eddys-efforts-to-replace-human-trials-with-computer-models/2009-12-10T18:34:55+00:00monthlyhttp://cardiobrief.org/2009/12/09/medtronic-cardiac-rhythm-device-unit-under-investigation-in-california/2009-12-09T23:28:33+00:00monthlyhttp://cardiobrief.org/2009/12/09/gao-fda-fails-to-make-adequate-changes-in-drug-safety-monitoring/2009-12-09T20:32:34+00:00monthlyhttp://cardiobrief.org/2009/12/08/many-dialysis-patients-undergoing-pci-receive-contraindicated-antithrombotics/2009-12-08T00:38:59+00:00monthlyhttp://cardiobrief.org/2009/12/08/new-mri-technique-uncovers-differences-in-mens-and-womens-hearts/2009-12-08T00:15:52+00:00monthlyhttp://cardiobrief.org/2009/12/07/cardiorenal-advisory-panel-to-take-up-nebivolol-for-heart-failure-in-january/2009-12-07T16:10:23+00:00monthlyhttp://cardiobrief.org/2009/12/06/rivaroxaban-einstein-at-ash-and-another-rock-on-the-road-to-approval/2009-12-09T17:51:49+00:00monthlyhttp://cardiobrief.org/2009/12/06/re-cover-at-ash-dabigatran-equals-warfarin-for-vte-treatment/2009-12-06T17:41:21+00:00monthlyhttp://cardiobrief.org/2009/12/05/industry-academic-researchers-and-clinical-trials-the-slippery-slope/2009-12-04T22:27:01+00:00monthlyhttp://cardiobrief.org/2009/11/20/einstein-at-ash-rivaroxaban-xarelto-prevents-recurrent-vte-but-bleeding-may-be-a-concern/2009-12-04T18:01:23+00:00monthlyhttp://cardiobrief.org/2009/12/04/bmj-risk-of-vte-after-surgery-is-higher-and-lasts-longer-than-expected/2009-12-04T15:13:45+00:00monthlyhttp://cardiobrief.org/2009/12/03/bmj-large-observational-study-finds-excess-cv-risk-for-sulphonylureas-but-benign-outcomes-for-tzds/2009-12-03T23:56:20+00:00monthlyhttp://cardiobrief.org/2009/12/03/us-justice-dept-weighing-criminal-charges-against-jj-over-natrecor-marketing/2009-12-03T18:25:49+00:00monthlyhttp://cardiobrief.org/2009/12/01/ama-its-hard-to-beat-the-framingham-risk-score/2009-12-01T20:00:55+00:00monthlyhttp://cardiobrief.org/2009/12/01/susan-shurin-to-serve-as-acting-director-of-nhlbi/2009-12-01T13:37:42+00:00monthlyhttp://cardiobrief.org/2009/11/30/circulation-exercise-may-help-slow-aging-process-by-protecting-telomeres/2009-11-30T21:06:19+00:00monthlyhttp://cardiobrief.org/2009/11/30/dronedarone-multaq-gains-eu-approval-for-atrial-fibrillation/2009-11-30T13:51:13+00:00monthlyhttp://cardiobrief.org/2009/11/25/nejm-very-low-troponin-t-levels-in-stable-cad-associated-with-death-and-hf-but-not-mi/2009-11-25T19:18:33+00:00monthlyhttp://cardiobrief.org/2009/11/24/report-new-niacin-scrips-rise-41-in-week-following-arbiter-6/2009-11-24T22:41:55+00:00monthlyhttp://cardiobrief.org/2009/11/24/jama-high-primary-pci-volume-doesnt-translate-into-lower-mortality/2009-11-24T18:38:57+00:00monthlyhttp://cardiobrief.org/2009/11/23/did-medicaid-pay-for-all-those-plavix-ads-on-the-news/2009-11-23T22:38:44+00:00monthlyhttp://cardiobrief.org/2009/11/23/vioxx-what-did-merck-know-and-when-did-it-know-it/2009-11-23T22:12:46+00:00monthlyhttp://cardiobrief.org/2009/11/22/one-week-later-the-arbiter-6-aftermath/2009-11-22T22:16:52+00:00monthlyhttp://cardiobrief.org/2009/11/20/fda-also-announces-safety-review-of-sibutramine-meridia/2009-12-07T16:54:19+00:00monthlyhttp://cardiobrief.org/2009/11/20/emea-investigating-increased-cardiovascular-risk-with-sibutramine/2010-02-10T00:45:40+00:00monthlyhttp://cardiobrief.org/2009/11/19/astrazeneca-submits-nda-for-brilinta-ticagrelor-and-fills-in-details-about-how-it-works/2009-11-19T14:09:46+00:00monthlyhttp://cardiobrief.org/2009/11/18/ahaaccscai-release-updated-stemi-and-pci-guidelines/2009-11-18T21:12:19+00:00monthlyhttp://cardiobrief.org/2009/11/17/fda-issues-public-health-advisory-on-interaction-between-clopidogrel-and-omeprazole/2009-11-17T23:31:53+00:00monthlyhttp://cardiobrief.org/2009/11/16/aha-arbiters-sunday-roller-coaster-ride-in-orlando/2009-11-17T21:45:59+00:00monthlyhttp://cardiobrief.org/2009/11/17/ken-baughman-dies-after-a-traffic-accident-in-orlando-during-aha/2010-02-18T08:18:55+00:00monthlyhttp://cardiobrief.org/2009/11/16/new-warnings-added-to-plavix-clopidogrel-label/2009-11-17T04:23:20+00:00monthlyhttp://cardiobrief.org/2009/11/16/aha-early-repolarization-on-ecg-associated-with-increased-risk-of-cardiac-death/2009-11-16T19:00:20+00:00monthlyhttp://cardiobrief.org/2009/11/15/niacin-to-take-center-stage-as-it-beats-ezetimibe-in-arbiter-6/2009-11-16T12:04:36+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-biventricular-pacing-preserves-lv-shape-and-function/2009-12-01T05:01:06+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-cangrelor-fails-to-find-a-championship-season/2009-11-15T16:44:20+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-ticagrelor-found-beneficial-in-stemi-subset-of-plato/2009-11-15T14:43:57+00:00monthlyhttp://cardiobrief.org/2009/11/14/the-empire-strikes-back-mercks-richard-pasternak-downgrades-arbiter-6/2009-11-14T23:46:23+00:00monthlyhttp://cardiobrief.org/2009/11/13/editorial-why-arbiter-6-is-important-and-not-important/2009-11-14T22:18:57+00:00monthlyhttp://cardiobrief.org/2009/11/13/26000-patients-enrolled-in-timi-50-trial-of-novel-antiplatelet-agent/2009-11-13T17:56:05+00:00monthlyhttp://cardiobrief.org/2009/11/12/william-ganz-co-inventor-of-catheter-and-early-promoter-of-thrombolysis-dead-at-90/2009-11-13T01:18:29+00:00monthlyhttp://cardiobrief.org/2009/11/13/get-ready-for-the-aha-in-orlando/2009-11-13T01:14:55+00:00monthlyhttp://cardiobrief.org/2009/11/11/fda-sends-warning-letter-to-ucla-cardiologist-charles-mckay/2009-11-12T19:56:48+00:00monthlyhttp://cardiobrief.org/2009/11/11/nejm-study-finds-risks-but-no-benefits-for-renal-revascularization/2009-11-11T22:03:45+00:00monthlyhttp://cardiobrief.org/2009/11/10/jama-statins-reduce-gallstones-simplified-lipid-assessment-without-fasting/2009-11-10T21:04:22+00:00monthlyhttp://cardiobrief.org/2009/11/10/arbiter-6-family-feud-and-the-survey-says/2009-11-10T19:22:30+00:00monthlyhttp://cardiobrief.org/2009/11/09/boston-scientific-issues-statement-on-the-death-of-donald-baim/2009-11-09T21:19:19+00:00monthlyhttp://cardiobrief.org/2009/11/09/observational-study-finds-increased-adverse-outcomes-with-increased-usage-of-carotid-stenting/2009-11-09T21:13:38+00:00monthlyhttp://cardiobrief.org/2009/11/06/donald-baim-interventional-cardiologist-and-boston-scientific-executive-dead-at-59/2009-11-07T13:54:55+00:00monthlyhttp://cardiobrief.org/2009/11/08/play-the-cme-game-at-home-or-at-the-aha/2009-11-10T22:08:03+00:00monthlyhttp://cardiobrief.org/2009/11/06/boston-scientific-closes-one-case-for-296-million-and-discloses-a-new-subpoena/2009-11-06T17:36:07+00:00monthlyhttp://cardiobrief.org/2009/11/05/ny-times-why-icds-are-like-maseratis-and-not-hondas/2009-11-06T01:49:13+00:00monthlyhttp://cardiobrief.org/2009/11/05/heartmate-ii-bypasses-fda-panel-and-may-get-destination-therapy-indication-soon/2009-11-05T18:06:37+00:00monthlyhttp://cardiobrief.org/2009/11/04/nejm-on-pump-cabg-beats-off-pump-cabg-at-one-year/2009-11-04T20:25:29+00:00monthlyhttp://cardiobrief.org/2009/11/03/cheerleading-for-science-anybody-have-a-better-idea/2009-11-03T18:31:44+00:00monthlyhttp://cardiobrief.org/2009/11/02/massachusetts-cardiologist-sues-lahey-clinic-after-being-fired-claims-hospital-had-close-ties-to-medtronic/2009-11-03T00:34:46+00:00monthlyhttp://cardiobrief.org/2009/11/02/small-niacin-imaging-study-looms-large-in-the-run-up-to-arbiter-6/2009-11-02T23:40:35+00:00monthlyhttp://cardiobrief.org/2009/11/02/fda-refuses-to-file-merck-application-for-ezetimibeatorvastatin-combination/2009-11-02T21:13:05+00:00monthlyhttp://cardiobrief.org/2009/11/02/exenatide-byetta-gains-first-line-indication-from-fda-but-also-a-warning/2009-11-02T20:43:43+00:00monthlyhttp://cardiobrief.org/2009/11/02/arbiter-6-wall-street-chorus-predicts-outcome-publication-and-editorials/2009-11-02T20:20:45+00:00monthlyhttp://cardiobrief.org/2009/11/02/beta-blockers-for-noncardiac-surgery-deemphasized-in-revised-accaha-guidelines/2009-11-02T15:58:07+00:00monthlyhttp://cardiobrief.org/2009/08/18/wall-street-guesses-arbiter-6-will-be-aha-late-breaker/2009-11-02T14:43:00+00:00monthlyhttp://cardiobrief.org/2009/08/27/arbiter-6-scheduled-as-aha-late-breaker-kastelein-to-be-discussant/2009-11-02T14:42:32+00:00monthlyhttp://cardiobrief.org/2009/07/08/arbiter-6-halts-trial-comparing-ezetimibe-and-niacin-terminated-early-by-steering-committee/2009-11-02T14:40:21+00:00monthlyhttp://cardiobrief.org/2009/10/30/halloween-trick-dont-treat-diabetes-with-esas/2009-10-31T01:55:27+00:00monthlyhttp://cardiobrief.org/2009/10/30/astrazeneca-update-on-ticagrelor-brilinta-raises-questions-about-reduced-efficacy-with-high-dose-aspirin/2009-10-30T17:30:05+00:00monthlyhttp://cardiobrief.org/2009/10/29/halloween-to-arrive-early-this-year-with-presentation-of-treat/2009-10-29T20:50:26+00:00monthlyhttp://cardiobrief.org/2009/10/29/study-suggests-statins-may-prevent-flu-deaths/2009-10-31T14:33:14+00:00monthlyhttp://cardiobrief.org/2009/02/23/chronology-of-prasugrel-controversy/2009-10-29T03:40:20+00:00monthlyhttp://cardiobrief.org/2009/10/28/uks-nice-allows-limited-use-of-prasugrel/2009-10-29T03:36:45+00:00monthlyhttp://cardiobrief.org/2009/10/28/review-article-highlights-differences-between-european-and-north-american-stemi-guidelines/2009-10-28T19:02:02+00:00monthlyhttp://cardiobrief.org/2009/10/27/senator-queries-nih-about-ballantyne-and-other-nih-grantees-who-took-vytorin-money/2009-10-27T19:52:02+00:00monthlyhttp://cardiobrief.org/2009/10/27/medicare-advisory-committee-delivers-mixed-review-for-af-catheter-ablation/2009-10-27T17:54:49+00:00monthlyhttp://cardiobrief.org/2009/10/26/fda-advisory-committee-to-review-primary-prevention-indication-for-crestor-rosuvastatin/2009-10-27T14:37:43+00:00monthlyhttp://cardiobrief.org/2009/10/26/women-and-mi-increasing-incidence-but-improved-survival/2009-10-26T20:48:28+00:00monthlyhttp://cardiobrief.org/2009/10/24/duke-cardiologist-to-be-new-president-of-gladstone-institutes/2009-10-24T22:03:07+00:00monthlyhttp://cardiobrief.org/2009/10/19/telmisartan-gets-fda-approval-for-cv-prevention-in-acei-intolerant-patients/2009-10-23T13:39:21+00:00monthlyhttp://cardiobrief.org/2009/10/22/betsy-nabel-to-leave-nhlbi-to-become-president-of-the-brigham/2009-10-23T00:26:56+00:00monthlyhttp://cardiobrief.org/2009/10/22/lancet-liraglutide-shows-considerable-promise-in-weight-loss-trial/2009-11-06T15:44:48+00:00monthlyhttp://cardiobrief.org/2009/03/13/new-diabetes-drugs-juggled-by-fda/2009-10-22T18:12:09+00:00monthlyhttp://cardiobrief.org/2009/10/21/fda-turns-down-kings-nda-for-corvue-binodenoson/2009-10-21T20:18:18+00:00monthlyhttp://cardiobrief.org/2009/10/20/medco-launches-14000-patient-head-to-head-comparison-of-clopidogrel-and-prasugrel/2009-10-21T09:43:53+00:00monthlyhttp://cardiobrief.org/2009/10/20/hospitals-getting-with-the-guidelines-are-not-getting-with-aldosterone-antagonism/2009-10-20T18:33:09+00:00monthlyhttp://cardiobrief.org/2009/10/16/more-allegations-about-enhance-fiasco-laid-out-in-vytorin-lawsuit-complaint/2009-10-16T18:15:26+00:00monthlyhttp://cardiobrief.org/2009/10/16/study-raises-concerns-about-trauma-treatment-in-growing-population-on-warfarin/2009-10-16T14:29:21+00:00monthlyhttp://cardiobrief.org/2009/10/16/crestor-gains-pediatric-fh-indication-from-fda/2009-10-16T13:18:06+00:00monthlyhttp://cardiobrief.org/2009/10/15/iom-report-smoking-bans-cut-heart-attacks-in-smokers-and-nonsmokers/2009-10-15T16:50:20+00:00monthlyhttp://cardiobrief.org/2009/10/14/meta-analysis-suggests-statins-may-help-fight-infections/2009-10-14T16:16:43+00:00monthlyhttp://cardiobrief.org/2009/10/13/brave-new-world-zen-trial-to-test-des-for-ed/2009-10-13T19:54:23+00:00monthlyhttp://cardiobrief.org/2009/10/13/10-years-after-columbia-heart-surgery-study-still-causing-problems/2009-10-12T23:16:34+00:00monthlyhttp://cardiobrief.org/2009/10/12/study-finds-increased-use-of-glucose-lowering-treatments-at-the-expense-of-statins-and-antihypertensives/2009-10-12T20:12:11+00:00monthlyhttp://cardiobrief.org/2009/10/06/elizabeth-taylor-twitters-the-news-shes-about-to-get-an-evalve-mitraclip-mitral-valve/2010-11-06T09:41:14+00:00monthlyhttp://cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/2009-10-09T00:16:13+00:00monthlyhttp://cardiobrief.org/2009/10/08/erosions-and-late-stage-thrombi-more-prevalent-in-women-and-younger-sudden-death-victims/2009-10-08T18:56:04+00:00monthlyhttp://cardiobrief.org/2009/10/07/october-thought-experiment-suppose-the-world-series-were-covered-like-the-nobel-prizes/2009-10-07T19:52:23+00:00monthlyhttp://cardiobrief.org/2009/10/05/hypertension-in-china/2009-10-07T03:14:57+00:00monthlyhttp://cardiobrief.org/2009/10/06/9-nontraditional-risk-factors-fail-to-gain-uspstf-recommendations-crp-comes-close/2009-10-06T19:28:30+00:00monthlyhttp://cardiobrief.org/2009/10/05/fda-posts-full-drug-approval-package-for-prasugrel/2009-10-05T17:35:27+00:00monthlyhttp://cardiobrief.org/2009/10/05/onglyza-saxagliptin-gains-european-approval/2009-10-05T15:09:49+00:00monthlyhttp://cardiobrief.org/2009/10/02/1st-patient-enrolled-in-dapt-study-testing-duration-of-antiplatelet-therapy-after-des/2009-10-02T16:08:25+00:00monthlyhttp://cardiobrief.org/2009/10/01/fda-alert-heparin-shipped-after-october-8-will-be-10-less-potent/2009-10-01T20:24:48+00:00monthlyhttp://cardiobrief.org/2009/10/01/lancet-review-will-most-babies-born-now-live-to-100/2009-10-01T15:40:33+00:00monthlyhttp://cardiobrief.org/2009/09/30/reverse-at-2-years-crt-may-help-prevent-progression-in-early-hf/2009-09-30T23:50:40+00:00monthlyhttp://cardiobrief.org/2009/09/29/fish-and-heart-failure-the-one-that-got-away/2009-09-30T00:32:53+00:00monthlyhttp://cardiobrief.org/2009/09/29/invitation-to-readers-my-mighty-team/2009-09-29T23:55:19+00:00monthlyhttp://cardiobrief.org/2009/09/28/home-care-for-acute-decompensated-heart-failure/2009-09-28T14:35:48+00:00monthlyhttp://cardiobrief.org/2009/09/25/fda-adds-pancreatitis-warning-to-januvia-label/2009-09-25T18:22:23+00:00monthlyhttp://cardiobrief.org/2009/09/25/cholesterol-prescriptions-from-senators-schumer-grassley-and-nelson/2010-03-31T18:39:35+00:00monthlyhttp://cardiobrief.org/2009/09/24/tct-cogent-provides-reassurance-on-use-of-ppis-with-clopidogrel/2009-09-25T18:20:55+00:00monthlyhttp://cardiobrief.org/2009/09/24/tct-fame-extends-its-15-minutes-out-to-2-years/2009-09-25T17:33:12+00:00monthlyhttp://cardiobrief.org/2009/09/24/3280/2009-09-24T21:51:18+00:00monthlyhttp://cardiobrief.org/2009/09/23/gregg-stone-no-longer-chairman-of-cardiovascular-research-foundation/2009-09-24T00:29:16+00:00monthlyhttp://cardiobrief.org/2009/09/23/tct-xience-outperforms-taxus-in-spirit-iv-but-no-difference-in-diabetics/2009-09-24T00:29:03+00:00monthlyhttp://cardiobrief.org/2009/09/21/flu-vaccine-may-prevent-flu-triggered-mis/2009-09-23T16:23:33+00:00monthlyhttp://cardiobrief.org/2009/09/22/accaha-publish-new-performance-measures-to-prevent-cv-disease/2009-09-23T16:23:17+00:00monthlyhttp://cardiobrief.org/2009/09/22/senators-ask-columbia-did-martin-leon-fail-to-disclose-millions-of-dollars-received-from-industry/2009-09-23T16:23:06+00:00monthlyhttp://cardiobrief.org/2009/09/21/wall-street-analyst-calls-prasugrel-launch-muted/2009-09-21T20:10:52+00:00monthlyhttp://cardiobrief.org/2009/09/21/circ-smoking-ban/2009-09-21T20:03:29+00:00monthlyhttp://cardiobrief.org/2009/09/18/company-and-wall-street-disagree-over-trial-results-of-diet-drug-lorcaserin/2009-09-18T21:34:47+00:00monthlyhttp://cardiobrief.org/2009/09/18/uk-study-high-risk-associated-with-10-15-year-cut-in-life-expectancy/2009-09-17T15:54:45+00:00monthlyhttp://cardiobrief.org/2009/09/16/nejm-writers-make-case-for-soda-tax/2009-09-17T14:14:10+00:00monthlyhttp://cardiobrief.org/2009/09/16/senate-investigation-uncovers-huge-expenditures-for-vytorin-cme/2009-09-22T21:13:48+00:00monthlyhttp://cardiobrief.org/2009/09/14/study-sheds-light-on-stroke-following-cardiac-surgery/2009-09-16T18:41:39+00:00monthlyhttp://cardiobrief.org/2009/09/14/everybody-in-the-risk-pool-survey-finds-frightening-increase-in-cv-risk/2009-09-14T20:21:14+00:00monthlyhttp://cardiobrief.org/2009/09/14/icds-in-women-a-new-meta-analysis-sparks-criticism/2009-09-14T20:17:57+00:00monthlyhttp://cardiobrief.org/2009/09/13/endothelin-receptor-blocker-darusentan-effective-in-resistant-hypertension/2009-09-12T23:09:01+00:00monthlyhttp://cardiobrief.org/2009/09/11/editor-insists-prasugrel-ghostwriter-go-public/2009-09-12T14:46:48+00:00monthlyhttp://cardiobrief.org/2009/09/10/abbott-to-acquire-evalve-developer-of-minimally-invasive-mitral-valve-repair-devices/2009-09-11T14:55:42+00:00monthlyhttp://cardiobrief.org/2009/09/10/acc-survey-finds-critical-shortage-of-cardiologists-now-and-in-the-future/2009-09-11T14:55:32+00:00monthlyhttp://cardiobrief.org/2009/09/09/phentermine-and-topiramate-a-slimming-combination/2009-09-11T14:55:20+00:00monthlyhttp://cardiobrief.org/2009/09/08/lifetime-exposure-to-lead-linked-to-increased-cv-risk/2009-09-08T18:12:33+00:00monthlyhttp://cardiobrief.org/2009/09/08/dronedarone-less-effective-but-safer-than-amiodarone-study-suggests/2009-09-08T14:50:00+00:00monthlyhttp://cardiobrief.org/2009/09/04/esc-the-shady-side-of-af-treatments/2009-09-08T03:02:49+00:00monthlyhttp://cardiobrief.org/2009/09/06/dr-nobody-in-jama-editors-flap-speaks-his-mind/2009-09-08T03:02:37+00:00monthlyhttp://cardiobrief.org/2009/09/05/circulation-publishes-lengthy-correction-of-mist-paper/2009-09-08T03:02:27+00:00monthlyhttp://cardiobrief.org/2009/09/03/are-low-carb-high-fat-diets-fads/2011-06-08T11:34:50+00:00monthlyhttp://cardiobrief.org/2009/07/07/chronology-of-the-jama-editors-controversy/2009-09-06T15:33:35+00:00monthlyhttp://cardiobrief.org/2009/02/16/pfo-and-migraine-the-next-chapter/2009-09-05T15:18:16+00:00monthlyhttp://cardiobrief.org/2009/09/03/fame-at-esc-benefits-of-ffr-hold-up-at-18-months/2009-09-03T15:46:26+00:00monthlyhttp://cardiobrief.org/2009/09/01/hiding-in-plain-sight-clinical-trial-registration-isnt-working-as-intended/2009-09-11T19:03:01+00:00monthlyhttp://cardiobrief.org/2009/09/02/fda-reviewer-reviews-his-own-prasugrel-review-in-nejm/2009-09-03T02:54:41+00:00monthlyhttp://cardiobrief.org/2009/09/02/syntax-at-esc-at-2-years-mis-in-pci-patients-begin-to-accumulate/2009-09-02T18:16:55+00:00monthlyhttp://cardiobrief.org/2009/09/02/jama-all-aboard-for-pci-but-no-need-to-rush/2009-09-01T21:34:48+00:00monthlyhttp://cardiobrief.org/2009/09/01/kyoto-heart-at-esc-have-arbs-finally-come-of-age/2009-09-01T19:13:22+00:00monthlyhttp://cardiobrief.org/2009/09/01/esc-icdmadit-crt/2009-09-01T08:24:49+00:00monthlyhttp://cardiobrief.org/2009/08/31/jupiter-at-esc-large-absolute-benefit-with-rosuvastatin-in-elderly-patients/2009-09-01T01:04:55+00:00monthlyhttp://cardiobrief.org/2009/08/31/esc-grace-documents-growing-use-of-pci-for-left-main-disease-in-acs/2009-08-31T22:51:51+00:00monthlyhttp://cardiobrief.org/2009/08/31/esc-reassurance-on-concomitant-use-of-ppis-and-antiplatelets/2009-08-31T15:05:21+00:00monthlyhttp://cardiobrief.org/2009/08/30/re-ly-at-esc-dabigatran-in-warfarin-finally-on-the-way-out/2010-02-12T21:10:47+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-high-dose-clopidogrel-aids-pci-for-acs-current-oasis-7/2009-08-30T23:55:44+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-ticagrelor-shows-potent-antiplatelet-effect-in-plato/2009-08-30T16:18:21+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-bivalirudin-and-otamixaban-in-acs/2009-08-30T16:15:44+00:00monthlyhttp://cardiobrief.org/2009/08/30/aaa-at-esc-aspirin-not-beneficial-in-asymptomatic-patients-with-low-abi/2009-08-30T15:07:26+00:00monthlyhttp://cardiobrief.org/2009/08/30/1st-day-esc-hot-lines-68415-randomized-patients/2009-08-30T08:35:40+00:00monthlyhttp://cardiobrief.org/2009/05/11/tacagrelor-bests-clopidogrel-in-l8000-patient-acs-trial-astrazeneca-claims/2009-08-30T06:16:52+00:00monthlyhttp://cardiobrief.org/2009/08/28/routine-use-of-stenting-in-carotid-stenosis-can-no-longer-be-justified/2010-02-27T00:52:26+00:00monthlyhttp://cardiobrief.org/2009/08/26/topol-and-teirstein-argue-about-stents-on-nprs-all-things-considered/2009-08-28T15:40:48+00:00monthlyhttp://cardiobrief.org/2009/08/25/editorial-prescription-for-medical-education-sunshine/2009-08-26T03:13:54+00:00monthlyhttp://cardiobrief.org/2009/08/26/sensitive-troponin-assays-enter-the-fray/2009-08-26T03:03:14+00:00monthlyhttp://cardiobrief.org/2009/08/25/jama-researchers-identify-genetic-variation-that-hinders-clopidogrel-effectiveness/2009-08-25T00:09:35+00:00monthlyhttp://cardiobrief.org/2009/08/24/testosterone-may-be-beneficial-in-hf/2009-08-24T22:51:15+00:00monthlyhttp://cardiobrief.org/2009/08/25/jama-risk-of-death-after-acs-diff-in-men-women/2009-08-21T16:34:56+00:00monthlyhttp://cardiobrief.org/2009/08/20/cardiologist-in-mcallen-texas-sentenced-to-4-years-in-prison/2009-08-21T14:58:56+00:00monthlyhttp://cardiobrief.org/2009/08/20/shanghai-cardiology-conference-putting-the-con-back-in-the-word-conference/2009-08-20T14:51:41+00:00monthlyhttp://cardiobrief.org/2009/08/19/is-it-time-to-change-the-guidelines-for-unprotected-left-main-disease/2009-08-20T01:05:51+00:00monthlyhttp://cardiobrief.org/2009/08/18/bmj-study-questions-whether-ongoing-use-of-rosiglitazone-is-justified-in-any-circumstance/2009-08-19T03:39:40+00:00monthlyhttp://cardiobrief.org/2009/08/18/get-ready-for-the-esc-in-barcelona/2009-08-18T20:18:51+00:00monthlyhttp://cardiobrief.org/2009/08/18/jama-papers-mi-outcomes-improving-hf-not-so-much/2009-08-18T17:35:40+00:00monthlyhttp://cardiobrief.org/2009/08/15/charm-substudy-in-lancet-spotlights-albuminuria-in-hf/2009-08-15T13:21:59+00:00monthlyhttp://cardiobrief.org/2009/08/14/2681/2009-08-14T17:58:29+00:00monthlyhttp://cardiobrief.org/daily1.02012-02-04T01:14:25+00:00